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Health and Human Performance

An Outcome Evaluation Ot An Outreach Program For Injection Drug
Thesis Chair; K. Ann Sonda^

A study was conducted to examine the eflfectiveness o f an intervention designed to
increase HIV and Hepatitis C preventative behaviors among injection drug users (IDUs)
residing in chemical dependency centers. The intervention was developed based on the
Informational-Motivation-Behavioral Skills Model (IMB). Seventy IDUs participated in
the study. Approximately one-half o f the participants received a one-hour HIV and
Hepatitis C prevention intervention with an indigenous outreach worker, while the other
half did not receive the intervention. A self-report survey was developed and was
designed to measure three determinants o f HIV preventive behaviors: 1) participants'
knowledge o f HIV and Hepatitis C prevention, 2) participants’ motivation to engage in
preventive behavior, and 3) participants’ intent and perceptions o f efficacy to perform the
behavioral skills needed to engage in preventative behaviors. The survey was
administered prior to and two weeks after the intervention to evaluate the effectiveness o f
the intervention. An ANCOVA revealed significant differences (F=.67, p<.05) on
posttest scores between the two groups. In addition, the intervention group demonstrated
important net gains on their average survey scores ft^om pretest to posttest in the
information, motivation, and behavioral components, while the control group did not.
These findings support the hypothesis that an HIV and Hepatitis C prevention outreach
program can be effective in increasing IDUs’ knowledge, motivation, and perceived
efficacy to perform preventative HIV and Hepatitis C behaviors. This study also
illuminates the need for theoretical based interventions that address HIV and Hepatitis C
risk behaviors among IDUs.
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CHAPTER I
Introduction to the Study
Statement o f the Problem
Human immunodeficiency virus (HIV), the cause o f AIDS, is the defining medical
and public health issue o f our generation and ranks among the greatest infectious disease
scourges in history (Fauci, 1999). AIDS, acquired immunodeficiency syndrome, was first
reported in the United States in 1981 and has since become a major worldwide epidemic.
Since 1981, more than 886,000 cases o f AIDS have been reported in the United States
and as many as 950,000 Americans may be infected with HIV, one-quarter o f whom are
unaware o f their infection (NIAID, 2003). Equally alarming is the number o f Americans
infected with the Hepatitis C virus. The Centers for Disease Control reports an estimated
2.7 million Americans are chronically infected with Hepatitis C (CDC, 2002b). An
estimated 25,000 people are newly infected with the Hepatitis C virus each year, causing
approximately 8,000-10,000 liver disease deaths among those infected (CDC, 2002b).
Injection Drug Use (IDU) is a significant risk factor for AIDS (CDC, 1982) and
the single most important risk factor for Hepatitis C infection (CDC, 1998; Garfien et al.,
1996). One third, approximately 240,000 o f the AIDS cases reported to date, can be
attributed to injection drug use (CDC, 2002) while approximately 50 to 95 percent o f
individuals infected with Hepatitis C report a link to injection drug usage (Garfien et al.,
1996). IDUs can introduce HIV and Hepatitis C into their drug community where,
through the sharing o f needles and injection equipment, it has the ability to spread rapidly
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and infect large proportions o f individuals who inject and share drugs (Habib, 2003). As a
result o f the high incidence o f HIV and Hepatitis C infection, effective preventative
interventions to assist IDUs adopt risk reduction behaviors are needed.
There are three common approaches to HIV and Hepatitis C prevention among
IDUs (Watters and Guydisk, 1994). The first o f these involves punishing IDUs for the
illegal use o f illicit d n ^ s and using the criminal justice system to remove IDUs fi-om
society (Morse et al., 1998). The second major approach involves treating drug use as an
illness and using abstinence based treatment approaches through long-term hospitalization,
methadone maintenance programs, outpatient, and self help groups (Watters and Guydisk,
1994). The third approach, harm reduction, suggests it is not always necessary to stop the
use o f illicit drugs but rather reduce the risk o f exposure to disease by using harmreduction methods to reduce the chance o f HIV infection among IDUs (Morse, et.al.,
1998).
The HIV and Hepatitis C prevention outreach program that will be evaluated in
this study. Taking it to the Population, is based on basic harm reduction principles that
aim to reduce rather than completely eliminate IDUs’ risk behaviors (Des Jarlais et al.,
1993). In addition, this intervention was developed utilizing the principles o f the
Informational, Motivational Behavioral Skills (IMB) model. The model, originally
developed in response to the HIV epidemic, has been used for understanding and
promoting various health behaviors. (Fisher and Fisher’s study as sited in (Fisher and
Fisher, in press)). According to the IMB model, HIV prevention information, motivation.
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and behavioral skills are the three determinants o f HIV preventative behavior (Fisher et al.,
2002). The likelihood that individuals will initiate and maintain patterns o f preventative
behavior depends on the extent to which individuals are well informed, motivated to act,
and possess the behavioral skills to act effectively (Fisher and Fisher, 2002). Thus, Taking
it to the Population incorporates information, motivational strategies, and behavioral skills
into the program to enhance the likelihood o f positive behavioral change. HIV and
Hepatitis C prevention outreach programs, such as Taking it to the Population^ have been
used as HIV and Hepatitis C prevention strategies for several years in Montana yet have
never been evaluated. In order to ftilly understand how to best assist IDUs to decrease
their risk for HIV and Hepatitis C, such intervention programs must be evaluated to
determine if they meet their objectives and ultimately decrease IDUs’ HIV and Hepatitis C
risks.
Purpose o f the Study
The purpose o f this study is to examine the effectiveness o f an intervention
designed to increase HIV and Hepatitis C preventative behaviors among injection drug
users (IDUs) in chemical dependency centers.
Hypothesis
There will be significant increases on IDUs’ average scores between the
intervention and control groups from pretest to posttest scores on the HIV and Hepatitis
Prevention Survey.
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Delimitations
1. Participants will be delimited to IDUs attending the HIV and Hepatitis C prevention
outreach program in Montana.
2. Participants in this study will be volunteers.
3. Data will be collected using surveys.
4. Data will be restricted to participants’ self-reports.
Limitations
1. Accuracy o f data is dependent upon the participants’ willingness and ability to answer
honestly and accurately.
2. Accuracy is dependent upon participants’ ability to understand the survey statements.
3. Responses may be dependent to social desirability.
Definition o f Terms
AIDS - Acquired immunodeficiency syndrome applies to the most advanced stages o f HIV
infection. The CDC defines AIDS as the presence o f at least one o f several opportunistic
infections or the presence o f fewer than 200 CD4 cells/mm^ in an HIV positive individual
(AIDS Foundation, 1997).
COOKER —A container used to dissolve drugs in water and to heat drug solutions
(NIDA, 2000).
COTTON - Used to filter out particles that could block the needle (NIDA, 2000).
HARM REDUCTION - An intervention approach that suggests it is not always necessary
to stop the use o f illicit drugs but rather reduce the risk o f exposure to disease by using
methods to reduce the chance o f HIV infection among IDUs (Morse et al., 1998)
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HEPATITIS C (HCV, formerly NON-A, NON-B HEPATITIS) - A contagious viral
disease that causes inflammation o f the liver (AIDS Foundation, 1997).
HEPATITIS C/CO-INFECTION WITH HIV- Patients infected with HIV are also
infected with the Hepatitis C virus (AIDSInfo, 2003).
HIGH RISK SEX -Unprotected anal, vaginal, or oral sex; multiple partners; and lack o f
treatment o f sexually transmitted diseases (STDs) (Strathdee, et al., 2001).
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) - Treatment regimens
recommended to aggressively suppress viral replication and progress o f HIV disease
(AIDS info, 2003).
HUMAN IMMUNODEFICIENCY VIRUS (HIV)- A slow-acting retrovirus believed to
be the sole or primary cause o f AIDS. There are 2 known types: HIV-1 and HIV-2 (AIDS
Foundation, 1997).
INJECTION DRUG USER (IDU) -A person who uses a drug that is administered with a
needle and syringe (AIDS Foundation, 1997).
Importance o f the Study
The results from the outcome evaluation o f the HIV and Hepatitis C prevention
HIV and Hepatitis C prevention outreach program. Taking it to the Population, will
provide the Montana Department o f Health and Human Services (DPHHS), as well as
other health organizations, with valuable information concerning HIV and Hepatitis C
prevention outreach programs. This information can be used as a framework to design
interventions that may reduce the incidence o f HIV and Hepatitis C among IDUs.
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CHAPTER II
Review o f Literature
HIV/AIDS in The United States
M ore than 830,000 cases o f AIDS have been reported in the United States since
1981 (NIAID, 2003). Through the 1980’s the incidence o f AIDS continually increased.
However, with the introductions o f antiviral drugs from the mid-1990s through 2001 the
incidence o f reported AIDS cases decreased. Unfortunately in 2002, the incidence o f
AIDS increased 2%, compared with 2001. Since 1996, trends in AIDS cases have become
less reflective o f the underlying trends o f HIV transmission due to the widespread use o f
Highly Active Antiretroviral Therapy also known as HAART. It is important recognize
that even though the number o f deaths among persons with AIDS continued to decline,
the prevalence o f HIV continues to increase (CDC, 2003a).
HIV is the virus that causes AIDS (CDC, 2002b). The virus can be transmitted in
four different ways: through sexual contact with an infected person, through the sharing o f
needles or syringes among injection drug users (IDUs), through contact with infected
blood, as well as from infected pregnant women who can pass HIV to their babies during
pregnancy or delivery as well as through breast-feeding (NAIAD, 2003).
In the United States, injection drug use and sexual contact are the two main routes
by which HIV is transmitted (AED, 2002). For injection drug users, transmission can
occur through direct or indirect sharing o f contaminated equipment. Additionally, the
high-risk sexual behaviors usually associated with drug use also put IDUs at risk for HIV.
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These risky sexual behaviors include unprotected anal, vaginal, and/or oral sex, as well as
multiple sex partners, and lack o f treatment o f sexually transmitted diseases (STDs)
(Strathdee, S.A., et al., 2001). To prevent transmission o f HIV among IDUs, it is clear
that efforts should focus on both safe injection practices and decreasing risky sexual
behaviors (CDC, 1982).
HIV/AIDS in Montana
As o f 2003 in Montana, 612 cases were reported that met the HIV/AIDS
definition; 265 resulting in death. Men who have sex with men (MSM) account for 63
percent o f the total HIV cases. Injection drug users (IDUs) account for 24 percent o f total
HIV/ AIDS cases. This includes 13 percent reporting only IDU, as well as 11 percent
reporting dual risk factors o f MSM and IDU. In addition, 45 percent o f heterosexual
AIDS cases are linked to a partner who injected drugs. When this “indirect” link is
considered, 29 percent o f all reported cases are linked to IDU (Montana DPHHS, 2004).
The remaining 23 percent o f HIV/AIDS cases in Montana where acquired through
transfusions related to hemophilia/coagulation disorder (2 percent), heterosexual contact
(11 percent), transfusion with blood or blood products (2 percent), or cases that are
currently under investigation (9 percent) (Montana DPPHS, 2004).
Hepatitis C in The United States
The Hepatitis C virus (HCV) infection is the most common chronic blood borne
infection in the United States (CDC, 1998). The Centers for Disease Control reports an
estimated 2.7 million Americans are chronically infected with Hepatitis C (CDC, 2002b),
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Most people chronically infected with Hepatitis C do not know they are infected because
they may not experience symptoms for 20-30 years after they are infected (CDC, 1998).
An estimated 25,000 people are newly infected with the Hepatitis C virus each year,
causing approximately 8,000-10,000 liver disease deaths among those infected (CDC,
2002b).
Like HIV, Hepatitis C can be transmitted through contact vsdth infected blood or
body fluids by ways o f unprotected sex, injection drug use, through the birth process, as
well as through blood transfusions. In addition. Hepatitis C is also transmitted through the
sharing o f infected toothbrushes or razor blades that contain blood or body fluids from an
infected person (CDC, 2004).
Injection drug use is the single most important risk factor for Hepatitis C virus
infection. Garfien and colleges (1998), estimate that 50 to 95 percent o f IDUs are infected
with Hepatitis C. Not only is Hepatitis C prevalent among IDUs but also it appears to be
acquired relatively soon after drug injection is initiated. One study estimating the
prevalence o f blood-bome viral infections among illicit IDUs, reported that 50 to 80
percent o f new IDUs became infected with Hepatitis C within 6 to 12 months o f first
injecting (Garfien et al., 1996).
Because HIV and Hepatitis C are both transmitted through exposure to infected
blood or body fluid, coinfections o f Hepatitis C and HIV are common (CDC, 2002c). In
2000, an estimated 240,000 persons were coinfected with Hepatitis C and HIV. HIV and
Hepatitis C coinfections account for approximately 30% o f those individuals with HIV
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infections (Sulkowski et al, 2000).
Hepatitis C in Montana
According to The Montana Department o f Health and Human Services (DPHHS),
6464 persons have been reported to be Hepatitis C positive in Montana (L. Bans, personal
communication, February 24, 2004). However, because most people chronically infected
with Hepatitis C are not aware that they are infected (CDC, 1998), the Montana
Department o f Public Health and Human Services, Hepatitis C Division, estimates there
are approximately 16,280 cases o f Hepatitis C in Montana. This is an estimate based on
National Hepatitis C data. Nationwide, approximately 16% o f the population is Hepatitis
C positive (L. Baus, personal communication, February 24, 2004).
Prevention o f HIV and Hepatitis C in the United States
As previously mentioned. Injection Drug Use is a risk factor for AIDS (CDC,
1982) and Hepatitis C (Garfien et al., 1996). Injection Drug Users account for one third,
approximately 240,000 o f the AIDS cases reported to date (CDC, 2002a) and
approximately 50 to 95 percent o f individuals infected with Hepatitis C report a link to
IDU (Garfien et al., 1996). IDUs who share injection equipment can introduce the viruses
into their drug community where they have the ability to spread rapidly and infect large
proportions o f individuals who inject and share drugs (Habib, 2003). IDUs become
infected and transmit the viruses to others in two, often interconnected, ways. The first is
the sharing o f blood contaminated syringes and injection paraphernalia such as water,
cookers, and cottons. The second method o f HIV and Hepatitis C transmission among
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IDUs is high-risk sex, which can be defined as unprotected sex, sex with multiple partners,
and/or feilures to treat STDs (AED, 2002).
There are three common approaches to HIV and Hepatitis C prevention among
IDUs (Watters and Guydisk, 1994). The first o f these involves punishing IDUs for the
illegal use o f illicit drugs and using the criminal justice system to remove IDUs from
society (Morse et al., 1998). In the late 1990’s, approximately 83 percent o f all state
prisoners (837,300) and approximately 73 percent o f all federal prisoners (64,000)
reported past drug use. One third o f state prisoners and one fifth o f federal prisoners
reported using drugs at the time they committed the offense for which they were in prison
(CDC, 2001). The large numbers o f drug users in the criminal justice system and their
high risk o f acquiring and transmitting HIV, STDs, and Hepatitis C, creates an urgent
need for high quality prevention, treatment, and care services for incarcerated individuals.
In addition, it is also crucial that inmates receive these prevention services after they are
released. Without these services, inmates return to their communities and often revert to
the behaviors that put them in prison. This increases the chances they will use drugs,
commit crimes, spread or acquire disease, and return to prison or jail (CDC, 2001).
The second major approach to HIV and Hepatitis C prevention involves treating
drug use as an illness and using abstinence based treatment approaches through long-term
hospitalization, methadone maintenance programs, outpatient, and self help groups
(Watters and Guydisk, 1994). The goal o f this approach is to provide guidance and social
support for eradicating drug use and is encouraged for IDUs who want to stop the use o f
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drugs but can’t do so on their own (Morse et a!., 1998). Abstinence-based programs are
based on the idea that the cessation o f all drug use and drug injection is the most effective
strategy for risk reduction (Morse et al., 1998). Although abstinence based drug
treatment is an ejBfective method for helping many IDUs overcome drug addiction and
reducing both needle and sex-related HIV risks (Des and Hubbard, 1999), some IDUs are
not ready to discontinue drug use (NIDA, 2000). Further, if IDUs do manage to
discontinue drug use, often times relapse occurs (Simpson and Marsh, 1986).
As a result, other prevention strategies, such as harm reduction, in addition to drug
abuse treatment are needed for those who continue to use drugs and those who are prone
to relapse (NIDA, 2000). The third HIV and Hepatitis C prevention approach, harm
reduction, is based on the belief that not all IDUs are ready to discontinue drug use
(NIDA, 2000). Harm reduction suggests it is not always necessary to stop the use o f illicit
drugs but rather reduce the risk o f exposure to disease by using harm-reduction methods
to reduce the chance o f HIV infection among IDUs (Morse et al., 1998). Harm reduction
operates under the basic assumption that IDUs are capable o f rational, informed choices
and when given the knowledge and opportunity to do so, they will choose to reduce harm
to themselves as well as to society. (Des Jarlais et al., 1993). It is a non-judgmental
approach that accepts drug use as a choice and neither condones or condemns it (Hilton et
al., 2001). Harm reduction is based on five principles. It offers a practical alternative that
focuses on the consequences o f harmful behaviors rather than whether the behavior is
morally right or wrong. It accepts alternatives to abstinence. It is based on a ‘bottom-up’
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approach of patient input and demand, rather than a ‘top-down’ policy. It is user friendly
and supports and accepts a ‘low-threshold’ for access to treatment. And finally, it is based
on compassionate simplicity and not on moral impracticality (Hilton et al., 2001). Some
examples o f harm reduction techniques are needle exchange programs, and instruction and
encouragement to clean injection equipment (Morse et.al., 1998).
In the National Institute on Drug Abuse Manual: NIDA Community Based
Outreach Model: A M anual To Reduce the R isk o f H IV and Other Blood Born Infections
in Drug Users, the following is suggested as a hierarchy o f harm reduction to prevention
the spread o f HIV and Hepatitis C among IDUs:
1. Stop using and injecting drugs
2. Enter and complete drug abuse treatment, including relapse prevention
3. Take the following steps to reduce personal and public health risks, if drug
injection continues
Never reuse or “share” syringes, water, or drug preparation
equipment
Use only syringes obtained from reliable sources (e.g., pharmacies,
syringe exchange programs)
Use a new, sterile syringe to prepare and inject drugs
If possible, use sterile water to prepare drugs; otherwise use clean
water fi-om a reliable source (such as fresh tap water)
Use new or disinfected container (“cooker”) and new filter
(“cotton”) to prepare drugs
Clean the injection site prior to injection with a new alcohol swab
Safely dispose o f syringes after one use. (NIDA, 2000)

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

13

Montana Injection Drug User Outreach Interventions
Montana’s Department o f Public Health and Human Service (DPHHS) supports
the implementation o f HIV and Hepatitis C outreach programs. According to the DPHHS
the goal o f IDU outreach interventions is to “reduce drug use behaviors that increase the
transmission o f disease” (Montana HIV Prevention Application, 2002).
The objectives o f the outreach programs in Montana include:
1. To have an outreach training curriculum that includes harm reduction
education
2. To increase outreach workers’ knowledge and understanding o f the IDU
community through training sessions
3. To increase professionals’ knowledge and understanding o f the IDU
community by training those who deal with IDUs to include HIV preventative
services in the treatment plan
4. To have available a resource referral packet for outreach worker’s to distribute
to their communities
5. To decrease the use o f shared IDU equipment through active outreach
activities as indicated by the distribution and collection o f information through
the self-assessment tool (Montana HIV Prevention Application, 2002)
Informational-Motivational-Behavioral Skills (IMB) Model
The Information-Motivation-Behavioral Skills (IMB) model can be used as a basis
for understanding HIV risk and prevention. (Fisher and Fisher, 2002). The model,
originally developed in response to the HIV epidemic, has been used for understanding
and promoting various behaviors including HIV prevention, (Fisher et al., 2002) and
health behavior change. (Fisher and Fisher’s study as sited in (Fisher and Fisher, in press)).
According to the IMB model, HIV prevention information, motivation, and behavioral
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skills are the three determinants o f HIV preventative behavior. (Fisher et al., 2002). The
likelihood that individuals will initiate and maintain patterns o f preventative behavior
depends on the extent to which individuals are well informed, motivated to act, and
possess the behavior skills to act effectively (Fisher and Fisher, 2002). These three
determinants are discussed in more detail below.
Information
The first component for HIV preventative behavior skill development and change,
according to the IMB model, is the use o f information that is directly relevant to HIV
transmission and prevention and is easily applied in an individual’s social setting (Fisher et
al., 2002). HIV preventative information, such as relevant fects about HIV and Hepatitis C
as well as information about transmission that is closely related to preventative behavior
enactment can serve as a guide for personal preventative actions and behavioral change
(Fisher and Fisher, 2002).
Often times, IDUs develop misconceptions about HIV and Hepatitis C risk
(Habib, 2003; Feldman and Biernacki, 1998). For example, IDUs tend to exhibit a sense o f
invulnerability related to contracting HIV and Hepatitis C and repeatedly perceive others,
not themselves, to be at risk (Morse et. al., 1998). This suggests a deficiency o f
knowledge about HIV and Hepatitis C (Habib, 2003). Studies show IDUs who were
knowledgeable about the risks associated with injection practices began making changes in
their behaviors to reduce their risks (Feldman and Biernacki, 1998). HIV and Hepatitis C
prevention interventions for IDUs should include educational programs to educate and
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correct misconceptions about HIV and Hepatitis C and to promote safer drug use
practices (Habib, 2003).
M otivation
The second component for HIV and Hepatitis C behavioral change according to
the IMB model, motivation, takes into account HIV preventative behavior as well as HIV
and Hepatitis C preventative motivation. The motivational conponent determines whether
well-informed individuals will be inclined to act on what they know concerning HIV and
Hepatitis C prevention. The likelihood o f an IDU engaging in preventative behavior is
dependent on both personal and social motivation (Fisher and Fisher 2002), as well as,
personal perceptions o f vulnerability to HIV and Hepatitis C infection (Rosenstock, 1996).
According to the IMB model, personal motivation can be influenced by internal as
well as external factors (Fisher and Fisher, 2002). Internal factors are directly related to an
individual’s motivation to avoid risk behavior (Habib, 2003). Individual perceptions o f
control, and self-efiScacy can influence motivation to abstain from drug use or engage in
harm reduction practices (Tortu et al. 2003).
Along with internal motivational factors, external motivational frictors are
important components o f HIV preventative behavioral change (Fisher and Fisher, 2002).
Social interventions are frequently cited as important motivational activities to stop the
spread o f HIV and Hepatitis C infection (Habib 2003; Nelson et al., 2002; Morse et al.,
1998; Valentine and Wright-DeAguero, 1998; Greenberg, et al., 1996). IDUs’ social
correlates, such as their peer and community networks, as well as their social support can
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influence HIV and Hepatitis C related behavior (Habib 2003; Nelson et a l, 2002; Morse et
al., 1998; Greenberg, et al., 1996.) IDUs injection practices can depend on the number and
the type o f social contacts he or she might have. For example, in a study by Habib (2003),
IDUs who shared needles and syringes were much more likely to have shared within their
immediate social circle (regular sexual partner, close friend, or family members) than with
a stranger (Habib, 2003). Another interesting finding is that IDUs with fewer social
contacts (low-density personal networks) are more likely to engage in risky behaviors
(Latkin et al., 1995). Additionally, research findings suggest that the role o f social support
has a different effect on IDU women as compared to IDU men. Abdul-Quader and
colleagues, (1990) in a study o f IDUs drug and sexual practice, foimd that women are
more positively affected by social support than men (Abdul-Quader et al., 1990). These
studies demonstrate that the use o f social network analysis may provide valuable insight
into the primary social factors affecting the transmission o f HIV and Hepatitis C (Morse
et, al., 1998)
Drug treatment centers can serve as a positive social network for IDUs (Des and
Hubbard, 1999). However, when IDUs enter drug treatment programs and do mans^e to
discontinue drug use, often times, relapse occurs following the completion o f the
treatment program (Simpson and Marsh, 1986). The chance o f relapse can be dependent
on whether or not IDUs return to their previous IDU community and previous injection
partners and fiiends, or whether they make entirely new contacts. The probability o f
relapse after exiting drug treatment is more likely if IDUs make contact and return to their
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former social networks, than if an IDU remains in and makes entirely new social networks.
(Des Jarlais et al., 1992)
Another important social factor that influences IDU risk behavior is the situation
or place that the risk behavior occurs. Injection drug use takes place in a variety o f
locations. IDUs inject alone or with groups o f other IDUs (Des Jarlais et al., 1993).
Results from a study by Habib (2003), showed that IDUs are more likely to share needles
and other injection equipment when they “hang out” with other IDUs. Habib (2003) also
suggests that situational factors such as not wanting to disrupt immediate pleasure can
increase the risk o f sharing injection equipment and IDU’s perceptions o f risks o f HIV and
Hepatitis C infection at the time (Habib, 2003).

This suggests that HIV and Hepatitis C

risks appear less significant to IDUs at such times. In order to adequately assess IDUs risk
behavior it is critical to understand the importance o f IDU’s social support and the social
network in which they reside (Habib, 2003).
Behavioral Skills
The third and final component o f the IMB model that helps determine whether
well-informed and well-motivated individuals will be capable o f enacting HIV and
Hepatitis C preventative behaviors effectively, is whether or not they have the behavioral
skills to do so. Behavioral skills for performing specific HIV and Hepatitis C preventative
acts include not only objective skills but also a sense o f self-efficacy for practicing HIV
and Hepatitis C prevention behavioral skills (Fisher et al., 2002). Individuals who inject
drugs must not only be skilled at cleaning injection equipment, but they must also be
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skilled at the negotiation o f safe injection. HIV and Hepatitis C prevention interventions
for IDUs should include educational programs about HIV and Hepatitis C to promote
safer drug use practices. However, the development o f skills to negotiate safe drug use
also should be an important part o f these interventions (Habib, 2003).
Outreach Education
Outreach programs can make valuable contributions to preventing blood-bome
infections such as HIV and Hepatitis C. Outreach programs are important to HIV and
Hepatitis C prevention because they work to enable the IDU population who are unable or
unwilling to stop injecting drugs to change the behaviors associated with risk o f HIV and
Hepatitis C infection (Needle et al., 1998). A typical outreach encounter involves face-to
fece communication intended to help IDUs modify their high-risk drug use and sexual
behavior. Often times, outreach workers distribute HIV/AIDS and Hepatitis C educational
information, bleach kits for disinfecting injection equipment when sterile equipment is not
available, and condoms for safer sex (Hilton et al., 2001) They also provide drug users
with referrals for drug treatment, syringe access and exchange programs, and HIV,
Hepatitis B, and Hepatitis C counseling and testing (NIDA, 2003).
Outreach programs are designed to reach high-risk IDUs and present and reinforce
risk behavior prevention messages within the IDU community (NIDA, 2000). Outreach
workers are in a unique position tb educate and influence their peers to modify their
behaviors to reduce the risks for HiV and other blood-bome infections (NIDA, 2003).
Outreach programs rely on indigenous outreach workers who generally live in or around
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the local community and are familiar with its drug use subculture. Many outreach workers
are recovering IDUs themselves, allowing them to draw on their personal experience to
relate to other IDUs (NIDA, 2000). In addition, outreach workers usually reflect the
ethnicity, gender, and cultural diversity o f the drug users targeted for the intervention
(NIDA, 2003) as well as having an intimate understanding o f ID U ’s lifestyles (Booth and
Koester, 1996).
Even though personal drug experience can positively influence an outreach
intervention, it is not an absolute necessity to be successful as an outreach worker. Some
important characteristics and abilities o f outreach workers include the ability to be able to
relate to active drug users on their own terms, the skill to communicate genuine concern
and respect for IDUs and their risks, the capacity to be advocates for those at risk by
relaying as much information and services as possible, as well as the capability to develop
a trusting relationship to IDUs (NIDA, 2000).
Outreach workers should also have appropriate skills and information levels
regarding prevention information. This includes a credible knowledge o f local resources
likely to be o f interest to IDUs such as drug treatment programs and services, HIV testing
and counseling, syringe exchange programs, and food programs. In addition, outreach
workers should possess adequate knowledge o f effective ways to reduce the chance o f
HIV infection and transmission, as well as organizational skills, accurate record keeping
abilities, successful networking with groups o f individuals at risk, and the ability to
recognize and maintain appropriate personal boundaries. Finally, and most importantly
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outreach workers must be able to work in the natural environments o f drug users and
within drug treatment and other service settings, both formally and informally (NIDA,
2000).
More than 15 years o f research on HIV/AIDS prevention interventions with IDUs
has shown that outreach is effective for different types o f IDUs in a variety o f different
settings (NIDA, 2003). Observational and quasi-experimental studies strongly indicate that
outreach programs reach IDUs effectively and help to reduce risk-taking behavior and
HIV incidence (Coyle et al., 1998; Des Jarlais et al., 1999) The most effective outreach
programs are peer-driven, utilizing indigenous people and users who are trained and paid
to assist their peers (Needle et al., 1998). In addition, theoretically based interventions or
components have been shown effective at reducing drug-using and sexual risk among
IDUs. For example, Sterk and colleagues (2003) performed a study analyzing outreach
programs that address sociocultural issues, such as knowledge, motivation and negotiation
skills, among African American women IDUs. This study evaluated an intervention based
on empirically as well as theoretically based concepts, such as the social-cognitive theory
and the theory o f reasoned action, to a non-theoretical based standard HIV prevention
intervention. The results o f this study showed that theoretically based interventions may be
more efective than non-theory based standards in reducing the frequency o f drug use and
the risk behaviors associated with drug use. These results indicate the importance o f
including theoretical components in interventions designed to reduce the risk o f HIV
infection among IDUs (Sterk et al., 2003).
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In addition, a meta-analysis conducted by Coyle and colleagues (1998) using
thirty-six observational and quasi-experimental studies showed consistent findings that
outreach-based interventions were effective in reducing HIV risk behaviors among IDUs
who participated in such interventions. Following IDUs participation in HIV outreach risk
reduction interventions, participants showed significant follow up reductions in measures
o f drug-related risk behaviors. Some examples o f important risk behavior changes include:
the termination o f injection drug use, a reduction in injection fi-equency, a reduction in the
number o f times IDUs reused or shared syringes and other injection equipment, as well as
an increased number o f IDUs who started to disinfect needles and other injection
equipment. In addition, sex-related risk behaviors were reduced as well. The findings
provide strong evidence that outreach-based intervention programs are effective for
reaching IDUs and provide means for behavior change. A majority o f IDUs who
participate in outreach programs reduce HIV related behaviors, which may be directly
related to a lower incidence o f HIV infections (Coyle et al., 1998).
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CHAPTER III
Methodology
Description o f Target Population
The populations evaluated in this study were injection drug users (IDUs) enrolled
in chemical dependency programs in Montana. This population consisted o f men and
women over the age o f 18, who attended the HIV and Hepatitis C prevention outreach
program. Taking it to the Population.
Study Design
The study consisted o f a pre-test, post-test quasi-experimental design. The study
was conducted at chemical dependency centers in Montana. Data was collected from the
experimental group (Taking it to the Population participants) prior to and two weeks after
participation in the intervention, and from the control group (non-Taking it to the
Population participants) at baseline levels and at a two week follow up. This design
provided within subject control, i.e. each subject served as his or her own control based on
the pre-test score, and between subject control, i.e., the HIV and Hepatitis C prevention
outreach program participants were compared to the control participants. This research
took place in the spring and summer o f 2004. The human subject’s application material
and çonsent forms were completed in accordance with The University o f Montana
Institutional Review Board (IRB) (Appendix A).
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Study Sample
Sam pling O f Program Participants (Experimental Group)
The experimental group was a convenience sample comprised o f volunteers from
clients enrolled in the chemical dependency center. The center required all clients to
attend the outreach workshop Taking it to the Population while they were enrolled in the
chemical dependency center; however, the clients were not required to participate in this
study. Prior to conducting the HIV and Hepatitis C prevention outreach workshop, the
certified HIV and Hepatitis C outreach workers provided participants with a thorough
descriptions o f the risks and the benefits o f participation in the study. After reviewing the
risks and benefits and stressing that this study was confidential and the participants’ names
were not be associated with answers or results o f the study, the outreach workers asked
for volunteers to participate in the study.
Sam pling o f Program Participants (Control Group)
The control group consisted o f clients who were enrolled in a second chemical
dependency treatment center. The control sample was also a convenience sample
comprised o f volunteers from the second chemical dependency center. At one o f the
regular group meetings held at the center, the chemical dependency center staff met with
the clients and infonned them about the risks and benefits o f participating in the study, as
well as the statement “that as a participant in no way will participant’s names be associated
with answers or results o f this study”. The chemical dependency staff then asked for
volunteers to participate in this study.
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Instrumentation
Survey Instrument
The researchers developed a survey instrument (Appendix B) based on the
Infbrmational-Motivational-Behavioral-SkUls Model (IMB), a thorough review o f
literature o f IDUs and the determinants o f unsafe injection practices, and on examination
o f existing surveys and surveys. Because o f difficulty in measuring the behavioral
component o f the IMB model in the treatment centers, the researchers measured the
participant’s intent to change behavior and each participant’s self-efficacy o f their ability
to perform the skills necessary to engage in preventative behaviors. The survey included
statements that relate to three major determinants o f behavior change:
1. Knowledge o f HIV and Hepatitis C
2. Motivation to engage in preventative behaviors
3. Intent and perceptions o f efficacy to perform the behavior skills needed to
e n g ^ e in preventative behaviors
There were also six statements that examined IDUs’ perceptions about whether it
was important to them that outreach workers display the following characteristics: trust,
genuine concern, knowledge, respect, and former IDU status. The final section o f the
survey asked about general demographic information.
Instrum ent R eliability and Validity
Instrument foce and content validity were established through the following
procedures. First, the instrument was reviewed by a panel o f experts, including two
professors with expertise in survey research and HIV prevention, the director o f an HIV
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and Hepatitis C outreach program, the director o f a City AIDS Council, the directors o f
the two participating chemical dependency centers, as well as several outreach workers
within the IDU community. Following suggested revisions, the survey was pilot tested
with a segment o f the target population who did not participate in the study. Following
the pilot test and further revisions, the final draft was completed.
Procedures
Experimental Group
The chemical dependency center required all clients enrolled at the center to attend
the one hour HIV and Hepatitis C prevention outreach program. Taking it to the
Population. Before beginning the study, an outreach worker fi-om Connection Jnc
informed the clients about the purpose o f the study and the inherent risks o f participating
in the study. The clients were then asked to voluntarily participate in the study and
complete a pre-test survey before the HIV and Hepatitis C prevention out reach program,
and a post test survey that was administered two weeks later. After volunteering to
participate in the study, the participants were asked to read and to sign an informed
consent (Appendix C), and to fift out the pre-test survey. Participants were asked not to
write their names anywhere on the survey, however, they were asked to place a unique
identifier on the top o f the survey for the purpose o f matching pre and post-test surveys.
Informed consent forms and surveys were collected separately to prevent names fi-om
being connected with the survey data. After the participants convicted the pre-test
survey, the outreach worker presented Taking it to the Population to all o f the clients at
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the chemical dependency center. Taking it to the Population focused on HIV and
Hepatitis C risk behavior reduction, which incorporated information about HIV and
Hepatitis C transmission and harm reduction, strategies designed to enhance motivation to
engage in HIV and Hepatitis C preventative behaviors, and information and strategies
designed to influence IDUs’ intentions and perceptions to perform HIV and Hepatitis C
preventative behaviors.
The participants that finished the chemical dependency treatment program before
the two week post-test survey was administered were asked to voluntarily provide the
outreach workers with contact information for the purpose o f follow-up. The contact
information, available only to the outreach worker, was used to mail follow up surveys to
the participants who had left treatment and wanted to complete the two week follow up
post-test survey. The volunteer participants were asked to return the post-test survey,
directly to the researchers at The University o f Montana, in a Self Addressed Stamped
Envelope.
Two weeks after the pretest survey and the HIV and Hepatitis C prevention
outreach program, the outreach worker returned to the chemical dependency center and
distributed the post-tests surveys to those individuals that volunteered to complete the
pre-test survey and that remained in the treatment center at the time o f the follow up.
Once again participants were asked not to write their names anywhere on the survey,
however, they were asked to place a unique identifier on the top o f the survey for the
purpose o f matching pre and post-test surveys. Upon completion o f the survey an

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

27

incentive was given to the volunteers for their participation in the study. Since the average
stay at the center was five weeks, this process was repeated at three, five-week intervals
to gather a larger sample size o f intervention group participants. The IDUs who already
had participated in the study and who were still enrolled at the chemical dependency
center were not allowed to participate in the study a second time.
Control Group
The control group consisted o f clients enrolled at a second chemical center in
Montana. Staff members fi'om the second chemical dependency directed the administration
o f the control group’s informed consents and the pre- and post-test surveys. At a
regularly scheduled meeting that all clients enrolled at center must attend, a staff member
fi’om the chemical dependency center informed the clients about the purpose o f the study
and the inherent risks o f participating in the study. The staff member then asked the clients
to voluntarily participate as the control group in the study. The clients that voluntarily
participated were asked to read and sign the informed consent form, and complete the pre
test survey. Participants were asked not to write their name anywhere on the survey,
however, they were asked to write a unique identifier at the top o f the survey for the
purpose o f matching pre and post-tests. To protect confidentiality the consents forms and
pre-test surveys were collected separately. The control group participants did not receive
any known HIV or Hepatitis C prevention activities between the pre-test and the post-test.
Two weeks after the pre-test was administered the staff member at the chemical
dependency center asked the clients who voluntarily participated in the pre test survey to
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voluntarily conplete a post-test survey. Once again participants were asked not to write
their name anywhere on the survey and only to write a unique identifier at the top o f the
survey for the purpose o f matching pre and post-tests. Since the average stay at the center
was five weeks, this process was repeated once more, five weeks later, to gather a larger
sample size o f control group participants. The IDUs who already had participated in the
study and who were still enrolled at the chemical dependency center were not allowed to
participate in the study a second time.
The Intervention
The experimental intervention consisted o f the one-hour HIV and Hepatitis C HIV
and Hepatitis C Prevention outreach program Taking It to the Population. The program
was based on the Informational-Motivational-Behavioral-Sldlls (IMB) Model which
suggests that the likelihood that IDUs will initiate and maintain patterns o f HIV and
Hepatitis C preventative behavior depends on the extent to which they are well informed,
motivated to act, and possess the behavioral skills to act effectively. The intervention was
conducted by an indigenous outreach worker who’s personal characteristics included the
following: the ability to relate to active drug users on their own terms, the skills to
communicate genuine concern and respect for IDUs and their risks, the capacity to be an
advocate for those at risk by relaying as much information as possible, and the capability
to develop a trusting relationship with IDUs. In addition, the outreach worker possessed
adequate knowledge o f effective ways to reduce the chance o f HIV and Hepatitis C
infection and transmission, as well as organizational skills, the ability to successfully
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network with groups o f individuals at risk, and the ability to recognize and maintain
appropriate personal boundaries.
The program was comprised of:
1. A participatory opening activity that emphasized the value and self-worth o f
the individuals in the audience.
2. A personal narrative told by the outreach worker that related her personal
struggles with addiction and injection drug use, and her success o f overcoming
her addiction and staying clean, to the individuals in the audience.
3. Information regarding HIV and Hepatitis C transmission and prevention,
accompanied by handouts.
4. Information about harm reduction strategies that could be used in the event of
a relapse
5. Information regarding support services and resources for the participants once
they were released from the treatment centers
6. A personnel story told by the outreach worker designed to stress the
importance o f social support and to increase the participants’ desire to ask for
support for their problems from their social community.
7- A verbal quiz o f the audience designed to reinforce their knowledge o f HIV
and Hepatitis C transmission, prevention strategies, harm reduction, and their
feelings o f self worth.
8. A final story told by the outreach worker regarding the principles by which she
lives to maintain her drug free life. This story was accompanied by a request
for the audience to read the principles, from a handout out-loud with her.

Program activities and information was designed to enhance IDUs’ knowledge o f
HIV and Hepatitis C transmission; IDUs’ knowledge o f how and where to locate HIV and
Hepatitis C resources; IDUs’ knowledge o f harm reduction; IDUs’ personal motivation to
engage in preventative behavioral interventions; IDUs’ perception o f their ability to
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establish social networks and receive social support outside o f their drug community;
IDUs’ perceptions o f their vulnerability to HIV and Hepatitis C associated with personal
risk; IDUs’ attitudes towards practicing HIV and Hepatitis C prevention interventions;
IDUs’ perceived efficacy to perform HIV and Hepatitis C preventative interventions; and
IDUs’ perceptions o f ability to resist urgency to inject with other IDUs. Through the
above components, the intervention’s overall objective was to promote factors that
support safer injection behaviors among IDUs’ and ultimately reduce the risk for HIV and
Hepatitis C.
Statistical Procedures
Data analysis involved comparison o f &equency distributions and the modes o f
variables between the intervention and control groups. T-tests and chi-square tests were
used to check the equivalence o f the intervention and control groups on demographic
variables. Comparison o f variables fi*om pretest to posttest was done using analysis o f
covariance (ANCOVA) with the pretest score for each variable serving as a covariate. A
priori the alpha level was set at 0.05. In addition, IMB statements were examined to
determine whether an important and practical difference existed between groups fi-om
pretest to posttest. This was calculated by scoring each participant’s pretest and posttest
survey, and taking the absolute value o f the pre-post test gain/loss. The scores for both the
experimental and control groups were then averaged, and a 12% increase was considered
an important between group difference. This indicated that all o f the participants answered
an average o f three more questions correct in the posttest as compared to the pretest.
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MANUSCRIPT
Abstract
A study was conducted to examine the effectiveness o f an intervention designed to
increase HIV and Hepatitis C preventative behaviors among injection drug users (IDUs)
residing in chemical dependency centers. The intervention was developed based on the
Informational-Motivation-Behavioral Skills Model (IMB). Seventy IDUs participated in
the study. Approximately one-half o f the participants received a one-hour HIV and
Hepatitis C prevention intervention with an indigenous outreach worker, while the other
half did not receive the intervention. A self-report survey was developed and was
designed to measure three deteiminants o f HIV preventive behaviors: 1) participants’
knowledge o f HIV and Hepatitis C prevention, 2) participants’ motivation to engage in
preventive behavior, and 3) participants’ intent and perceptions o f efiScacy to perform the
behavioral skills needed to engage in preventative behaviors. The survey was administered
prior to and two weeks after the intervention to evaluate the effectiveness o f the
intervention. An ANCOVA revealed significant differences (F=.67, p<.05) on posttest
scores between the two groups. In addition, the intervention group demonstrated
important net gains on their average survey scores fi’om pretest to posttest in the
information, motivation, and behavioral components, while the control group did not.
These findings support the hypothesis that an HIV and Hepatitis C prevention outreach
program can be effective in increasing IDUs’ knowledge, motivation, and perceived
efficacy to perform preventative HIV and Hepatitis C behaviors. This study also
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illuminates the need for theoretical based interventions that address HIV and Hepatitis C
rb k behaviors among IDUs.
Introduction
Human immunodeficiency virus (HIV), the cause o f AIDS, is the defining medical
and public health issue o f our generation and ranks among the greatest infectious disease
scourges in history (Fauci, 1999). AIDS, acquired immunodeficiency syndrome, was first
reported in the United States in 1981 and has since become a major worldwide epidemic.
Since 1981, more than 886,000 cases o f AIDS have been reported in the United States
and as many as 950,000 Americans may be infected with HIV, one-quarter o f whom are
unaware o f their infection (NIAID, 2003). Equally alarming is the number o f Americans
infected with the Hepatitis C virus. The Centers for Disease Control reports an estimated
2.7 million Americans are chronically infected with Hepatitis C (CDC, 2002b). An
estimated 25,000 people are newly infected with the Hepatitis C virus each year, causing
approximately 8,000-10,000 liver disease deaths among those infected (CDC, 2002b).
Injection Drug Use (IDU) is a significant risk factor for AIDS (CDC, 1982) and
the single most important risk factor for Hepatitis C infection (CDC, 1998; Garfien et al.,
1996). One third, approximately 240,000 o f the AIDS cases reported to date, can be
attributed to injection drug use (CDC, 2002) while approximately 50 to 95 percent o f
individuals infected with Hepatitis C report a link to injection drug usage (Garfien et al.,
1996). IDUs can introduce HIV and Hepatitis C into their drug community where,
through the sharing o f needles and injection equipment, the diseases have the ability to

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

33

spread rapidly and infect large proportions o f individuals who inject and share drugs
(Habib, 2003). As a result o f the high incidence o f HIV and Hepatitis C infection among
IDUs, efforts to develop effective preventative interventions to assist IDUs in adopting
HIV and Hepatitis C risk reduction behaviors are needed.
There are three common approaches to HIV and Hepatitis C prevention among
IDUs (Watters and Guydisk, 1994). The first o f these involves punishing IDUs for the
illegal use o f illicit drugs and using the criminal justice system to remove IDUs fi'om
society (Morse et al., 1998). The second major approach involves treating drug use as an
illness and using abstinence based treatment approaches through long-term hospitalization,
methadone maintenance programs, outpatient, and self help groups (Watters and Guydisk,
1994). The third approach, harm reduction, suggests it is not always necessary to stop the
use o f illicit drugs but rather reduce the risk o f exposure to disease by using harm
reduction methods to reduce the chance o f HIV infection among IDUs (Morse, et.al.,
1998).
Harm Reduction through Outreach
Harm reduction programs are important to HIV and Hepatitis C prevention
because they work to enable the IDU population who are unable or unwilling to stop
injecting drugs to change their behaviors associated with risk o f HIV and Hepatitis C
infection (Needle et al., 1998). Outreach is a commonly used harm reduction approach
that is designed to decrease the likelihood o f transmission o f HIV and Hepatitis C among
IDUs. A typical outreach encounter involves face-to face communication intended to help

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

34

IDUs modify their high-risk drug use and sexual behavior. Outreach programs are
designed to reach IDUs and present and reinforce prevention messages within the IDU
community (NIDA, 2000). Indigenous outreach workers who generally live in or around
the local community and are familiar with its drug use subculture are a key component in
outreach programs. Many outreach workers are recovering IDUs themselves and can
draw on their personal experience to relate to other IDUs (NIDA, 2000). In addition,
outreach workers usually reflect the ethnicity, gender, and cultural diversity o f the drug
users targeted for the intervention (NIDA, 2003) as well as having an intimate
understanding o f ID U ’s lifestyles (Booth and Koester, 1996). Outreach workers are in a
unique position to educate and influence their peers to modify their behaviors to reduce
the risks for HIV and other blood-bome infections (NIDA, 2003).
More than 15 years o f research on HIV/AIDS prevention interventions with IDUs
has shown that outreach is eflfective for diSerent types o f IDUs in a variety o f different
settings (NIDA, 2003; Des Jarlais et al., 1999; Coyle et al., 1998). The most eflfective
outreach programs are peer-driven, utilizing indigenous people and users who are trained
and paid to assist their peers (Needle et al., 1998). A meta-analysis conducted by Coyle
and colleagues (1998) using thirty-six observational and quasi-experimental studies
showed consistent findings that outreach-based interventions were eflfective in reducing
HIV risk behaviors o f IDUs who participated in such interventions. Following IDUs
participation in HIV outreach risk reduction interventions, participants showed significant
follow up reductions in measures o f drug-related risk behaviors. Some examples o f
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important risk behavior changes include: the termination o f injection drug use, a reduction
in injection frequency, a reduction in the number o f times IDUs reused or shared syringes
and other injection equipment, as well as an increased number o f IDUs who started to
disinfect needles and other injection equipment. In addition, sex-related risk behaviors
were reduced as well. The findings provide strong evidence that outreach-based
intervention programs are effective for reaching IDUs and provide means for behavior
change. A majority o f IDUs who participate in outreach programs reduce HIV related
behaviors, lowering the incidence o f HIV infections (Coyle et al., 1998).
Theoretically Based Interventions
Theoretically based interventions have also demonstrated effectiveness in reducing
drug-use and sexual risk among IDUs. For example, Sterk and colleagues (2003) carried
out a study analyzing outreach programs that address sociocultural issues, such as
knowledge, motivation and negotiation skills, among Afiican American women IDUs.
This study evaluated an intervention based on empirically and theoretically based
concepts, such as the Social-Cognitive Theory and the Theory o f Reasoned Action, to a
non-theoretical based standard HIV prevention intervention. The results o f this study
showed that theoretically based interventions may be more effective than non-theory based
standards, in reducing the frequency o f drug use and the risk behaviors associated with
drug use. These results indicate the importance o f including theoretical components in
interventions designed to reduce the risk o f HIV infection among IDUs (Sterk et al.,
2003).
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The Intervention: Taking it to the Population
The HIV and Hepatitis C Prevention Outreach Program evaluated in this study.
Taking it to the Population, was developed utilizing the principles o f the InformationalMotivational-Behavioral Skills (IMB) Model. The model, originally developed in
rép o n se to the HIV epidemic, has been used for understanding and promoting various
health behaviors (Fisher and Fisher’s study as sited in (Fisher and Fisher, in press)).
According to the IMB model, HIV prevention information, motivation, and behavioral
skills are the three determinants o f HIV preventative behavior (Fisher et al., 2002). In
other words, the likelihood that individuals will initiate and maintain patterns o f
preventative behavior depends on the extent to which individuals are well informed,
motivated to act, and posses the behavioral skills to act effectively (Fisher and Fisher,
2002). Thus, Taking it to the Population incorporates information, motivational
strategies, and behavioral skills into the program to enhance the likelihood o f positive
behavioral change.
Methods
Design
The study was designed to assess whether IDUs who completed the HIV and
Hepatitis C Prevention Outreach Program, Taking it to the Population, achieved
significantly higher post-test scores on the HIV and Hepatitis C Prevention Survey
compared to those who did not attend the outreach program. The study used a pre-test,
post-test quasi-experimental design. It took place at two chemical dependency centers in
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Montana. Data was collected from the intervention group prior to and two weeks after
participation in the intervention, and from the control group at baseline levels and at a two
week follow up. This design provided vyithin subject control, i.e. each subject served as
his or her ow n comparison based on the pre-test score, and between subject control. Le.,
the HIV and Hepatitis C prevention outreach program participants, intervention group,
were compared to the control group participants.
Instrum entation
The researchers developed a survey. The HIV and Hepatitis C Prevention Survey,
(Appendix B) based on the Informational-Motivational- Behavioral Skills Model (IMB); a
thorough review o f literature regarding the determinants o f unsafe injection practices; and
examination o f existing surveys. Because o f the difficulty m measuring the behavioral
component o f the IMB model while participants were residing in the treatment centers, the
researchers measured the participant’s intent to change behavior and their self-efficacy
regarding their ability to perform the skills necessary to engage in preventative behaviors.
The survey included 24 statements that related to three major determinants o f behavior
change as suggested by the IMB mode. Participants could respond “Yes”, “No”, “Not
Sure”, or “Does not apply to me” to each o f the 24 statements. The survey took the
participants 10 to 20 minutes to complete. The three components o f the IMB Model,
which according to the model comprise the determinants o f behavior change, along with
the survey statements related to each determinant are listed below:
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Inform ation Regarding H IV and H epatitis C Prevention:
1. Knowledge o f HIV and Hepatitis C transmission
2. Knowledge o f how and where to locate HIV and Hepatitis C resources
3. Knowledge o f harm reduction
M otivation to engage in preventative behaviors including:
4. Personal motivation to engage in preventative behaviors
5. Perceptions o f vulnerability to HIV and Hepatitis C associated with
personal risk
6. Perception o f ability to establish social networks and receive social
support outside one’s drug community
7. Attitudes towards practicing HIV and Hepatitis C prevention
interventions
Intent and perceptions o f efficacy to perform the behavior skills needed to engage
in preventative behaviors including:
8. Perceived efficacy to perform HIV and Hepatitis C preventative
behaviors
9. Perceptions o f ability to resist urgency to inject with other IDUs

There were also six statements that examined IDUs’ perceptions about whether it
was important to them that outreach workers display the following characteristics: trust,
genuine concern, knowledge, respect, and former IDU status. The final section o f the
survey contained 23 questions requesting general demographic information.
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Instrument fece and content validity were established through the following
procedure; First, the instrument was reviewed by a panel o f experts, including two
professors with expertise in survey research and HIV prevention, the director o f an HIV
and Hepatitis C outreach program, the director o f City AIDS Council, the directors o f the
two participating chemical dependency centers, as well as several outreach workers within
the IDU community. Following suggested revisions, the survey was pilot tested with a
segment o f the target population not participating in the study. Following the pilot test
and further revisions, the final draft was completed.
Participants completing both the pretest and the posttest were assigned scores
based on the number o f correct responses to the 24 (yes/no/not sure/ does not apply to
me) statements. For example a perfect score reflecting a high degree o f knowledge,
motivation, and efficacy to perform HIV and Hepatitis C preventative behaviors would be
a 24. If a participant answered half o f the questions correctly, he/she would receive a
score o f 12/24 for an overall score o f 50%. “Not sure” was considered a wrong answer,
however, if an IDU answered “Does not apply to me” this question was completely
factored out o f the denominator and the numerator o f the total score. For example if an
IDU answered 22 questions correctly, and answered the remaining two questions “Does
not apply to me” he/she would receive a 22/22 for a total score o f 100%.
Subjects
The intervention group consisted o f a convenience sample comprised o f volunteers
from clients enrolled in a pre-release chemical dependency center. The center required all
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clients to attend the HIV and Hepatitis C Prevention Outreach Program, Taking it to the
Population, while they were enrolled at the center; however, the clients were not required
to participate in this study. To be eligible, participants had to be 18 years o f age or older,
and have been an illegal injection drug user at one time. Prior to conducting the HIV and
Hepatitis C Prevention Outreach Program, the certified HIV and Hepatitis C outreach
workers provided participants with a thorough description o f the risks and the benefits o f
participation in the study. After reviewing the risks and benefits and stressing the
anonymous nature o f the study, the outreach workers asked for volunteers who were
wÜlii^ to complete the pre and posttests. .
The control group consisted o f a convenience sample o f volunteers who were
enrolled in a second pre-release chemical dependency treatment center. To be eligible,
participants had to be 18 years o f age or older and have been an illegal injection drug user
at one time. At one o f the regular group meetings held at the center, the chemical
dependency center staff met with the clients and informed them about the risks and
benefits o f participating in the study, as well as the anonymous nature o f the study. The
facilitators then asked for volunteers to participate in the control group. .
Intervention
The intervention consisted o f a one-hour HIV and Hepatitis C Prevention outreach
program. Taking it to the Population. The program was developed based on the
Informational Motivational Behavioral Skills (IMB) Model which suggests that the
likelihood that IDUs will initiate and maintain patterns o f HIV and Hepatitis C
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preventative behavior depends on the extent to which they are well informed, motivated to
act, and possess the behavioral skills to act effectively. The intervention was conducted by
an indigenous outreach worker whose personal characteristics included those described in
the literature as important to outreach effectiveness such as: the ability to relate to active
drug users on their own terms, the skills to communicate genuine concern and respect for
IDUs and their risks, the capacity to be an advocate for those at risk by relaying as much
information as possible, and the capability to develop a trusting relationship with IDUs. In
addition, the outreach worker possessed adequate knowledge o f effective ways to reduce
the chance o f HIV and Hepatitis C infection and transmission, as well as organizational
skills, the ability to successfully network with groups o f individuals at risk, and the ability
to recognize and maintain appropriate personal boundaries (NIDA, 2000).
The program was comprised of:
1. A participatory opening activity that emphasized the value and self-worth o f
the individuals in the audience.
2. A personal narrative told by the outreach worker that related her personal
struggles with addiction and injection drug use, and her success o f overcoming
her addiction and staying clean, to the individuals in the audience.
3. Information regarding HIV and Hepatitis C transmission and prevention,
accompanied by handouts.
4. Information about harm reduction strategies that could be used in the event o f
a relapse, i.e. how to locate clean injection equipment; how to clean used
injection equipment; how to negotiate safer injection practices, etc.
5. Information regarding support services and resources for the participants once
they were released from the treatment centers.
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6. A personnel story told by the outreach worker designed to stress the
importance o f social support and to increase the participants' desire to ask for
support for their problems from their social community.
7. A verbal quiz o f the audience designed to reinforce their knowledge o f HIV
and Hepatitis C transmission, prevention strategies, harm reduction, and their
feelings o f self worth.
8. A final story told by the outreach worker regarding the principles by which she
lives to maintain her drug free life. This story was acconç>anied by a request
for the audience to read the principles, from a handout out-loud with her.
Program activities and information were designed to enhance IDUs’ knowledge o f
HIV and Hepatitis C transmission; knowledge o f how and where to locate HIV and
Hepatitis C resources; knowledge o f harm reduction; personal motivation to engage in
preventative behavioral interventions; perceptions o f their ability to establish social
networks and receive social support outside o f their drug community; perceptions o f their
vulnerability to HIV and Hepatitis C associated with personal risk; attitudes towards
practicing HIV and Hepatitis C prevention interventions; perceived efficacy to perform
HIV and Hepatitis C preventative behaviors; and perceptions o f ability to resist urgency to
inject with other IDUs. Through the above components, the intervention’s overall
objective was to promote factors that support safer injection behaviors among IDUs’ and
ultimately reduce the risk for HIV and Hepatitis C.
Procedures
Intervention Group: The chemical dependency center required all clients enrolled
at the center to attend the one-hour HIV and Hepatitis C prevention outreach program.
Before beginning the study, the outreach worker informed the clients about the purpose o f

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

43

the study and the inherent risks o f participating in the study. The clients were then asked
to voluntarily participate. Those who volunteered were asked to read and sign an
informed consent (Appendix C), and to fill out the pre-test survey. Participants were
asked not to write their names anywhere on the survey, however, they were asked to place
a unique identifier on the top o f the survey for the purpose o f matching pre and post-tests.
Informed consent forms and surveys were collected separately to prevent names fi-om
being connected with the survey data. After the participants completed the pre-test survey
the outreach workers presented the HIV and Hepatitis C prevention program to all o f the
clients at the chemical dependency center. Two weeks after the pretest survey, the
outreach worker returned to the chemical dependency center and distributed the posttest
surveys to those individuals that volunteered to complete the pre-test survey and that
remained in the treatment center at the time o f the foUow up. The participants who
completed the chemical dependency treatment program before the two week posttest
survey was administered were asked to voluntarily provide the outreach workers with
contact information for the purpose o f follow-up. The contact information, available only
to the outreach worker, was used to mail follow up surveys to the participants who had
left treatment and wanted to complete the two week follow up post-test survey.
Participants were asked to return the post-test survey, directly to The University o f
Montana, in a self addressed stamped envelope. Since the average stay at the center was
five weeks, this process was repeated at three five week intervals to gather a larger sangle
size o f intervention group participants. The IDUs who already had participated in the
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study and who were still enrolled at the chemical dependency center were not allowed to
participate in the study a second time.
Control Group: The control group consisted o f clients enrolled at a second
chemical dependency center in Montana. Staff members from the second chemical
dependency center were provided explicit verbal and written instructions for the
administration o f the control group’s informed consents and the pre- and post-test
surveys. A staff member informed clients about the study during a regularly scheduled
meeting. The purpose o f the study and the inherent risks o f participating in the study were
explained at that time. The staff member then asked the clients to voluntarily participate in
the control group. The clients that volunteered were asked to read and sign the inJformed
consent form and complete the pre-test survey. As with the intervention group,
participants were reminded to not write their names anywhere on the survey, however,
they were asked to write a unique identifier at the top o f the survey for the purpose o f
m atchii^ pre and post-tests. To protect confidentiality the consent forms and pre-test
surveys were collected separately. Two weeks after the pre-test was administered the
staff member at the chemical dependency center asked the clients who voluntarily
participated in the pre-test survey to voluntarily complete a post-test survey. The control
group participants did not receive any known HIV o r Hepatitis C prevention activities
between the pre-test and the post-test.
Since the average stay at the center was five weeks, this process was repeated five
weeks later to gather a larger sample size o f control group participants. The IDUs who

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

45

already had participated in the study and who were still enrolled at the chemical
dependency center were not allowed to participate in the study a second time.
Statistical M ethods
Data analysis involved comparison o f frequency distributions and the modes o f
variables between the intervention and control groups. T-tests and chi-square tests were
used to check the equivalence o f the intervention and control groups on demographic
variables. Comparison o f variables from pretest to posttest was done using analysis o f
covariance (ANCOVA) with the pretest score for each variable serving as a covariate. A
priori the alpha level was set at 0.05. In addition to an examination o f statistical
differences, variables were examined to determine whether there existed an important and
practical difference between groups from pretest to posttest. This was determined by
taking the absolute value o f the pre-post test gain o f each group. A 12% increase was
considered an important difiference and indicated that all o f the participants answered an
average o f three more questions correct in the posttest as compared to the pretest
Results
A total o f 70 IDUs participated in the intervention or control group procedures.
The cohort consisted o f 39 intervention subjects and 31 control subjects. Two subjects
were eliminated from the study because they reported previous exposure to the
intervention. Seventy five percent o f those who completed a pre-test also completed a
post-test. As illustrated in Table 1, the mean age o f the participants was 32.10 years (o
=10.31), 59% o f the participants were male and 73% identified themselves white. Eighty-
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one percent o f the participants were heterosexual, 47% were married or in a committed
relationship, and 61% o f the participants had children. Overall there was variability in the
level o f education, however, sixty-two percent o f the population had at least graduated
high school or attained a GED. In addition, 49% o f the population was unemployed at
baseline. One hundred percent o f the population had been in jail or prison at one time and
86% o f the participants identified themselves as substance users. Sixty-seven percent o f
the injection drug users stated they had shared injection equipment at one time and a
majority o f the participants had been tested for HIV/AIDS (87%) and Hepatitis C (89%).
O f the participants tested, one participant had tested positive for HIV/AIDS (2%), while
14 participants had tested positive for Hepatitis C (22%). In addition, 29% o f the
participants had been diagnosed with a mental illness, and 43% were taking prescription
medications. Fifty-three percent o f the participants had been in a treatment facility only
once, while remaining participants had been in a fecility two or more times.
Intervention Group vs. Control Group at Baseline
Baseline chi-square tests revealed no statistically significant differences between
subjects in the intervention group (n=34) and subjects in the control group (n=31) with
respect to all but one demographic variable. There was a significant difference in the
number o f children reported by the control group as compared to the intervention group.
Seventy-seven percent (n=24) o f participants in the control group reported having at least
one child, while only 49% (n=19) o f intervention group participants reported having at
least one child at base line level (Table II).
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D ifferences Between Control and Intervention Group
The pretest and posttest scores on the HIV Hepatitis C Prevention Survey were
scored twice by the primary investigator to ensure the accuracy o f the two scores assigned
to each subject. The intervention group that attended Taking it to the Population and the
control group that received no intervention were compared using analysis o f covariance,
ANCOVA. Those cases where the participant completed a pretest but not a posttest were
omitted from the analysis. Before the inferential statistical data analysis was conducted,
the data were evaluated to determine the degree to which the assumptions o f ANCOVA
were met. All the assumptions were tested at the .05 level. The homogeneity o f
regression for the covariate pretest scores on the dependent variable posttest scores was
similar for the intervention and control groups (p=.4239) indicating that the ANCOVA
assunption o f homogeneity o f regression slopes was met. The result o f ANCOVA
revealed statistically significant improvement from pretest to posttest (F=.6474, p=.0475)
for those who were exposed to the Taking it to the Population intervention compared to
those who were not. An effect size (ES) o f .32 was calculated. The effect size is
expressed as the separation between populations due to the independent variable. It
increases with greater differences between means and decreases with larger standard
deviations (Aron & Aron, 1999). In this study, the ES is interpreted as the proportion o f
variance explained in the posttest by the pretest scores. Cohen provides a guide for
interpreting ES: .20 as smaU ES, .50 as a medium ES, and .80 as a large ES (Cohen,
1988). Using this criterion, the effect size in this study is small to medium.
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Additional examination o f the paired pretest and posttest scores found that the
intervention group that attended Taking it to the Population showed an important gain
from the mean pretest (69.5, SD =14.1) to the mean posttest scores (78.2, SD =11.8) as
compared to the control group in the pretest (75.7, SD = 13.4) and the posttest (72.7, SD
= 16.3). It is interesting to note that the control group demonstrated lower HIV and
Hepatitis C Prevention Survey scores at posttest than at pretest.
The significant difference between the intervention and the control group on the
HIV Hepatitis C Prevention Survey can be further analyzed in relationship to the three
conqjonents o f the theoretical model used in this study; information, motivation, and
behavioral skills. The statements on the survey associated with each component are
discussed below in relationship to their contribution to the overall differences between the
intervention and control group.
Inform ation
According to the IMB Model, being in possession o f adequate information is the
first o f three primary determinants o f HIV preventative behavior change. Information
should be directly relevant to HIV transmission and prevention and easily applied m an
individual’s social setting (Fisher et al., 2002). Nine statements on the survey addressed
foctors in the informational component. Statements for which there were practical and
important gains (gains greater than 12%) in the intervention group are listed in Table IV.
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M otivation
Motivation was the second determinant that contributed to the statistically
significant difference between the intervention and control groups. The motivational
component o f the IMB model determines whether well-informed individuals wUl be
inclined to act on what they know concerning HIV and Hepatitis C prevention. Eleven
statements on the survey addressed the motivation component that contributed to this
gain. Statements for which there were practical and important gains (gains greater than
12%) in the intervention group are listed in Table V.
Behavioral
The third and final determinant that influences whether well-informed and wellmotivated individuals are capable o f performing HIV and Hepatitis C preventative
behaviors effectively is whether or not they have the behavioral skills to do so. Behavioral
skills for perforrning specific HIV and Hepatitis C preventative acts include not only
objective skills but also a sense o f self-efiScacy for practicing HIV and Hepatitis C
prevention behavioral skills (Fisher et al., 2002). Individuals who inject drugs must not
only feel confident that they have the skills to clean injection equipment, but they must
also feel confident that they will be able to negotiate safe injection. Four statements on
the survey addressed the behavioral component that contributed to the overall statistical
significance in this study. Statements for which there were practical and important gains
(gains greater than 12%) in the intervention group are listed in Table VI.
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Perceptions o f Outreach Workers Characteristics
Participants were also asked their opinion about a variety o f outreach worker
characteristics that were listed in the literature as important to the success o f outreach
interventions. Table VII Usts the five statements on the survey addressing individual
characteristics o f outreach workers.
Discussion
This study demonstrates that a one-hour HIV and Hepatitis C prevention
program. Taking it to the Population, delivered by an indigenous outreach worker can be
an eflfective HIV and Hepatitis C prevention intervention for the IDU population. More
specifically, in this study, the intervention positively affected participants knowledge,
motivation, and perceived behavioral skills related to HIV and Hepatitis C prevention.
Two weeks post intervention, the effects o f Taking it to the Population had resulted in an
overall mean gain o f 12% on the HIV and Hepatitis C Prevention Survey in the
intervention group as compared to the control group. This suggests that every IDU who
participated in Taking it to the Population increased his or her score on the HIV and
Hepatitis C Prevention Survey by an average o f 12% (each participant answered an
average o f three more questions correctly).
The IMB model was used as a guide to examine specific changes in three
behavioral determinants identified by the theoretical model: knowledge, motivation, and
behavioral skills. IDUs participating in the intervention demonstrated important gains in
mean scores in all three areas.
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In the first area identified by the model, information, IDUs became more
knowledgeable about how and where to find clean needles. This knowledge is important
since IDUs who do not know where to locate clean needles increase the likelihood o f
sharing equipment. In addition, knowledge o f resources to assist with employment and
housing, and knowledge o f testing locations consistently increased in the intervention
group firom pretest to posttest.
In the second area identified by the model, motivation, the intervention group
participants reported increased motivation to get tested for AIDS and Hepatitis C,
increased confidence in the ability to use clean and disinfected injection equipment, as well
as increased motivation to practice safer sex. Consistent with previous reports (Habib,
2003; Tortu et a l, 2003), the likelihood IDUs wUl engage m preventative behavior is
dependent on personal motivation to avoid risk behaviors and individual attitudes towards
abstaining jfrom drug use or engaging in harm reduction practices. Based on our findings,
we suggest that HIV and Hepatitis C prevention programs for IDUs in chemical
dependency centers should continue to highlight the risk o f HIV and Hepatitis C infection
and transmission, along with incorporating methods to increase IDUs’ motivation to
practice preventative behaviors.
The most noticeable changes occurred in the third area described in the IMB
Model, intentions and perceptions to perform behavior skills. Post intervention, the
participants reported increased intentions to discuss HIV and Hepatitis C with fi-iends. In
addition, participants demonstrated enhanced confidence in negotiating clean injection
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equipment and an increase in their perception o f their ability to refuse a “dirty” needle.
Further, participants reported an increased perception o f self-control to stop oneself when
clean equipment is not available. Consistent with other research (Habib, 2003), this study
demonstrates the importance o f incorporating a behavioral skills component into
interventions that seek to enhance IDUs perceived efficacy to perform HIV and Hepatitis
C prevention behaviors and perceived ability to resist urgency to inject with others without
sterile equipment.
Perceptions o f Outreach Worker Characteristics
Results fi-om this study suggest that it is important that outreach workers
demonstrate genuine concern for IDUs, establish a trusting relationship, demonstrate
credible knowledge relating to HIV and Hepatitis C, understand that IDUs have the right
to make their own decisions about drug use, and show respect for IDUs by understanding
their dignity and self worth. Overall, the baseline scores were high, demonstrating IDUs’
opinions and perceptions match previously researched characteristics o f outreach workers.
In addition, consistent with findings from the National Institute on Drug Abuse (2002),
IDUs who participated in this study did not report high scores for the statement o f being
more comfortable getting information about AIDS or Hepatitis C from outreach workers
who are former IDUs. This is an important finding for organizations planning on
implementing future programs like this one. An outreach worker who previously injected
drugs is not perceived by IDU participants to be an essential component o f outreach
education as long as the outreach worker is knowledgeable, establishes a trusting
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relationship, shows respect, and is genuinely concerned for participants in the outreach
program.
In considering the clinical significance and practical value o f this study’s results, it
is important to think about other factors in addition to statistical significance. Service
providers considering the adoption o f an HIV Hepatitis C prevention intervention, such as
Taking it to the Population, should note that the program is inexpensive and relatively
easy to implement. In addition, it produced a small to medium effect size (.32) around the
issue o f harm reduction for IDUs, an issue o f considerable concern for individuals
involved in HIV and Hepatitis C prevention. This effect size, although not large, suggests
that changes are happening as a result o f the intervention. However, while this program
appears to be effective, it must be noted that it is not a quick fix for the complex,
multifaceted issue o f HIV and Hepatitis C prevention among IDUs. Injection drug users
must continue to be exposed to HIV and Hepatitis C prevention strategies that should be
reinforced throughout their stay at chemical dependency centers.
Limitations
In order to adequately interpret the results o f this study, several limitations must be
kept in mind. It was not possible to draw a random probability sample o f the IDU
population, therefore this study employed a non-probability convenience sample fi-om
chemical dependency centers and as a result sampling bias might have occurred.
Furthermore, it is clear that this sample is not representative o f all IDUs and therefore
results may only be generalized to populations similar to this sample. In addition, this
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study was made up o f a relatively small sample size. The resulting low statistical power
interfered with our ability to conduct individual analysis o f the three separate components
described in the IMB model. This study also relied on self-reported behavior, much like
most HIV-behavior change research, and reports o f privately occurring activities may be
susceptible to inaccuracy and depend on the honesty and willingness o f participants to
share private information in an anonymous survey.
Another limitation may be the internal validity o f the instrument. Unfortunately,
only face and content validity were established and the instrument may not accurately
measure what it was intended to measure. In addition, the participants were assessed at
two points in time and because the follow-up time was only two weeks, it proved difficult
to draw conclusions regarding the long-term effects o f the intervention. .
Conclusion
As previously mentioned, HIV is the defining medical and public health issue o f
our generation and ranks among the greatest infectious disease scourges in history (Fauci,
1999). Hepatitis C also is a major public health issue and is the most common chronic
blood borne infection in the United States (GDC, 1998). The modes o f transmission and
methods o f prevention for these two diseases are clearly known. Until vaccines
preventing the transmission o f the two diseases are developed, effective prevention
interventions must be developed to help prevent the spread o f the viruses. Findings from
this study suggest that the intervention. Taking it to the Population, may be an effective
prevention intervention for individuals who are in treatment for injecting drug use.
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In this study, the intervention group participants attended an hour long
intervention focusing on information, motivation, and behavioral determinants o f HIV and
Hepatitis C preventative behavior. The control group did not receive any HIV and
Hepatitis C interventions d u rii^ the length o f this study. All participants completed a
pretest and a posttest, which provided detailed information on their knowledge,
motivation, and perceived efficacy to practice HIV and Hepatitis C preventative behaviors.
Outcome results suggest that this intervention positively affected IDUs’ overall knowledge
o f HIV (information), motivation to engage in preventative behaviors, and perceived
efficacy to perform preventative behaviors. This outcome was statistically significant and
the net gain on the survey between the two groups was important.
Additional research is needed to characterize the durability and the sustainability of
this intervention. A larger randomly selected sample would increase the breadth o f this
study to gain an enhanced understanding o f HIV and Hepatitis C preventative behavior
change among IDUs. In addition, a longer follow-up period would also assist in drawing
improved conclusions regarding the long-term adoptions o f safer injection practices to
prevent HIV and Hepatitis C among IDUs.
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Table I Demographic M easures
Age (years)

Sex
Male
Female
Ethnicity
White
American Indian/Alaska Native
Black or African American
Hispanic Latino Chicane
Asian or Pacific American
Bi-racial or multiracial/ethnic
Education
< High school diploma
High school diploma / GED
Trade vocational school
Some College
College Graduate
Graduate/Professional School
Children (yes)
Married, or in a committed relationship
Sexual orientation
Heterosexual
Homosexual
Bisexual
Unsure
Employed (yes)
Individual yearly Income
<20,000
>20,000
Jail or prison (yes)
Substance Abuser (yes)
Shared injection equipment (yes)
Tested for AIDS (yes)
Results of AIDS test
Positive
Negative
Don't know
(yes)
Tested for Hepatitis
test
Results of Hepatitis
Positive
Negative
Don't know
Diagnosed with a mental illness (yes)
Take prescription medicines (yes)
Number of times in treatment
1

2

3
4
5
6

70

32.10

41
29

58.6%
41.4%

50
11
1
2
1
4

72.5%
15.9%
1.4%%
2.9%
1.4%
5.8%

11
34
4
19
2
1
43
(yes) 33

14.3%
62.19
5.7%
27.1%
2.9%
1.4%
61.4%
47.1%

57
8
3
2
34

81.4%
11.4%
4.3%
2 . 2%
48.6%

44
20
70
60
47
61

62.9%
28.6%
100.0%
85.7%
67.1%
87.1%

1
52
4
62

1 . 6%
85.2%
6.6%
88.6%

14
32
11
20
30

22.6%
51.6%
17.7%
28.6%
42.9%

37
13
9
8
2
1

52.9%
18.6%
12.9%
11.4%
2.9%
1.4%
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Table II Demographic M easures
Variable
Age (years)
Sex
Male
Female
Ethnicity
White
American Indian/
Alaska Native
Black or African American
Hispanic Latino Chicano
Asian or Pacific American
Bi-racial or multiracial
Children (yes)
Education
< High school diploma
High school diploma / GED
Trade vocational school
Some College
College Graduate
Graduate/Professional School
Married/committed
(yes)
Sexual orientation
Heterosexual
Homosexual
Bisexual
Unsure
Employed (yes)
Individual yearly Income
<20,000
>20,000

Jail or prison (yes)
Substance Abuser (yes)
Shared injection equip, (yes)
Tested for AIDS (yes)
Results of AIDS test
Positive
Negative
Don't know
Tested for Hepatitis C (yes)
Results of Hepatitis C test
Positive
Negative
Don't know
Diagnosed w/mental illness(yes
Take prescript, meds (yes)
Number of times in treatment
1
2
3
4
5
6

Experimental
39
31.28

[10.84]

Control
31
33.52

[9.51]

22
17

56.4%
43.6

19
12

61.3%
38-7%

28

71.8%

22

71. 0%

5

12.8%

6

24

19.4%
3, 2 %
3, 2 %
3. 2 %
3. 2 %
77.4%***

1

1

2 . 6 %%

4
19

10.3%
48.7%***

7
16
2
11
2
1
15

17.9%
41.0%
5.1%
28.2%
5.1%
2 . 6%
38.5%

3
18
2
8

9.7%
58 .1%
6.5%
25.8%

18

58 .1%

32
6

82.1%
15.4%

25
2

1

2.6

2

20

51.3%

13

80. 6%
6.5%
6.5%
6.5%
41. 9%

9
26
39
33
28
35

23.2%
66.7%
100.0%
84.6%
71.8%
89.7%

11
18
31
27
19
26

0
30
4
37

0 . 0%

1

85.7%
11.4%
94.9%

22

3.8%
84 .6%

25

80.6%

7
18
10
)11
19

18.9%
46.2%
25.6%
28.2%
48.7%

7
15

2 2 . 6%

9
11

56 .0%
3.2%
29. 0%
35.5%

20
8
5
4
2

51.3%
20.5%
12.8%
10.3%
5.1%

17
5
4
4

54.8%
16.1%
12 .9%
12 .9%

1
1
1

2

1

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

35. 5%
58 .1%
1 0 0 . 0%

87 .1%
61. 3%
83 .9%

3.2%
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Table III ANCOVA
M ean Pretest

M easure
Total Score on the HIV
Hepatitis C Prevention
Survey

Intervention
N=39
69.5 (14.1)

Control
N =31
75.7
(13.4)

Mean Posttest
Intervention
N=39
78.2(11.8)

Control
N =3i
72.7
(1 6 3 )

Knowledge of H IV an d H epatitis C
P retest
G roup
I know where to get clean injecting
equipment needles, cottons, and cookers.
When I finish this treatment program I want
to contact an organization like Connections,
Inc. that will help me find resources such as
jobs and housing
I know where to get tested for AIDS and
Hepatitis C.

df
1

Posttest

Intervention
Control
Intervention
Control

66-7%
77.4%
53.8%
58.1%

79.5%
77.4%
69.2%
51.6%

Intervention
Control

89.7%
100%

100%
96.8%

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

F ratio
P value
F=.67
p=.0475

Net
G ain
12.8%
21.9%

13.5%
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Motivation To Engage In HIV And Hepatitis C Preventative Behaviors
Group
Pretest Posttest
Net
Gain
I am confident I will get tested for AIDS and
Intervention 59.0%
74.7%
19.8%
Hepatitis C in the next six months
Control
67.7%
63.3%
1 am confident that if I inject drugs I know
Intervention 50.0%
71.8%
23.7%
how to clean and disinfect needles and
Control
56.7%
54.8%
cookers and get clean cotton
In the future to protect myself against AIDS
Intervention 79.5%
82.1%
11.6%
or Hepatitis C, if I inject drugs, I am
Control
83.9%
74.9%
confident I can use a clean needle, cooker,
and a new cotton to protect myself against
AIDS or Hepatitis C.
Intervention 66.7%
28.4%
In the future, if I have sex, I will practice
78.9%
safer sex (use condoms).
Control
83.9%
67.7%

Table VI Intent and perceptions o f efficacy to perform the behavior skills needed to engage in

Intent and perceptions of efficacy to perform the behavior skills needed to engage in
preventative behaviors
Net
Group
Pretest Posttest
Gain
34.0%
Intervention 41.0%
71.8%
When I finish this treatment program I plan
51.6%
Control
54.8%
to discuss AIDS and Hepatitis C with my
fiiends.
Intervention 71.8%
82.1%
13.5%
In the future, if I inject drugs, I would feel
77.4%
Control
80.6%
comfortable insisting on using clean needles,
cottons, and cookers with a friend(s).
79.5%
29.0%
In the future, if I inject drugs, I would be able Intervention 66.7%
71.0%
54.8%
Control
to refuse if a fiiend o f mine asked me to inject
with a “dirty” needle?
66.7%
18.1%
Intervention 61.5%
In the future, if I inject drugs, I would be
48.4%
61.3%
Control
able to stop myself fi*om injecting if my
friends or I don’t have a clean needle?
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Table VII Perceptions o f Outreach W orkers Characteristics

I am more comfortable getting information about AIDS or
Hepatitis C if the person who tells me about them is a
former Injection Drug User because he or she can relate to
me
It is very important to me that the person who talks to me
about AIDS and Hepatitis C is genuinely concerned about
me.

Intervention

P articipants
Score
69.2%

Control

54.8%

Intervention

82.1%

Control

80.6%

It is very important to me that I can trust the person who
talks to me about AIDS or Hepatitis C.
It is very important to me that the person who talks to me
about AIDS and Hepatitis C seems very knowledgeable
about ways to reduce AIDS and Hepatitis C infection.

Intervention
Control
Intervention

89.7%
90.3%
100.0%

Control

90.3%

It is very important to me that the person who talks to me
about AIDS or Hepatitis C shows me respect by
understanding my dignity and self-worth.

Intervention

100.0%

Control

83.9%

It is very important to me that the person who talks to me
about AIDS or Hepatitis C respects me by accepting the
feet that I have the right to make my own decisions about
drug use.

Intervention
Control

94.9%
87.1%

G roup
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1. PU R PO SE O F T H E RESEA C H P R O JE C T
Introduction
The pandemic o f HIV, the precursor to AIDS, is one o f the largest infectious disease
outbreaks in history, as well as the defining medical and public health issue o f our
generation. An estimated forty-two million people are currently living with HIV/AIDS. In
2002 alone, approximately five million people were infected with HIV. According to the
World Health Organization, about 14,000 new HIV infections are contracted daily.
Despite the massive efforts to prevent the spread o f HIV, it is estimated that anofiier 45
million people will be infected by the year 2010. Injection Drug use is a risk factor for
HIV/AIDS. O f the 886,575 cumulative AIDS cases diagnosed as o f 2002, a total o f
240,268 occurred among injection drug users (IDUs). O f the 556 cases o f HIV/AIDS in
Montana, 25% report a direct link with mjectmg drug use (IDU).
Injection drug use also is the single most important risk factor for Hepatitis C virus
infoction as well. An estimated 50 to 95 percent o f IDUs are infected with Hepatitis C.
The Hepatitis C virus (HCV) infection is the most common chronic blood borne infoction
in the United States. The Centers for Disease Control reports an estimated 2.7 million
Americans are chronically infected with Hepatitis C. Most people chronically infected with
Hepatitis C do not know they are infected because they may not experience synptom s for
20-30 years after they are infocted. An estimated 25,000 people are newly infoeted with
the Hepatitis C virus each year, causing approximately 8,000-10,000 liver disease deaths
among those infected.
Effective HIV and Hepatitis C preventative interventions designed to assist IDUs adopt
risk reduction behaviors are therefore needed. HIV and Hepatitis C educational outreach
programs, such as Taking it to the Population, have been used, as HIV prevention
strategies for several years in Montana, yet have never been evaluated. In order to fully
understand how we can best assist IDUs to decrease their risk for HIV we must evaluate
such intervention programs to see if they meet their objectives.
Purpose
The purpose o f this study is to determine if Taking to the Population, an educational HIV
and Hepatitis C prevention outreach program, held at in-patient chemical dependency
centers are effective in promoting safer injection practices among injection drug users.
The program is based on the Informational Motivational Behavioral skills model which
suggests that the likelihood that IDUs will initiate and maintain patterns o f HIV and
Hepatitis C preventative behavior depends on the extent to which they are well informed,
motivated to act, and possess the behavior skills to act effectively.
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2. THE SUBJECTS
The human subjects are injection drug users (IDUs) currently enrolled in chemical
dependency programs, over the age o f 18, at two sites in Montana. T te members o f this
population are not considered physically vulnerable, but there are some concerns over
their psychological and social vulnerability due to the stigma attached to their drug usage.
3. RECRUITING SUBJECTS
Sampling o f Taking it to the Population Participants (experimental group)
The experimental group will consist o f clients enrolled in a chemical dependency treatment
center in Montana. The center requires all clients to attend the outreach workshop Taking
it to the Population wdüle they are enrolled in the program. The facilitators o f Taking it to
the Population are certified Hepatitis and HIV educators and will ask for volunteers for
the study after providing a thorough description o f the risks and benefits o f participation in
the study.
Sampling o f non-educational outreach program participants (control group)
The control group will consist o f clients who are enrolled in a second chemical
dependency treatment center. At one o f the regular group meetings held at the center, the
j^ iiitato rs o f Taking it to the Population will meet with the clients and inform them about
the risks and benefits o f participating in the study. The facilitators will then ask for
volunteers. A small incentive will be offered to those clients who agree to participate in
the study.
4. WHERE THE STUDY WILL TAKE PLACE
The research will be undertaken during the spring and summer semester 2004 in Montana.
Workshops will be held and data will be collected at two chemical dependency treatment
centers in Montana.
5. ACTIVITIES THE SUBJECTS W ILL PERFORM
We will collect information from the experimental group {Taking it to the Population
participants) prior to and two weeks after participation in the program, and fi-om the
control group at a baseline level and at a two week follow up.
Experimental group
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The chemical dependency center requires all o f it’s clients to attend the one hour
educational outreach program Taking it to the Population organized through Connections
Inc. Taking it to the Population focuses on HIV and Hepatitis C risk behavior reduction,
which incorporates 1) HIV and Hepatitis C preventative information 2) HIV and Hepatitis
C preventative motivation 3) and HIV and Hepatitis C preventative behavior skills.
Clients who are in attendance at the program wül be asked to voluntarily participate in the
study. Before the program begins, study volunteers will be asked to read and to sign an
informed consent (please see attached Informed Consent form) and will be given a written
and verbal explanation o f the purpose o f the study (please see attached Explanation o f the
Study form). They also will be asked to fill out a survey. Informed consent forms and
surveys will be collected separately so that no names can be connected with the survey
data. Participants will, however, be asked to place a unique identifier on the top o f the
survey for the purpose o f matching pre and posttest surveys. After the program,
participants will be asked to voluntarily provide the outreach workers from Connections
Inc. with contact information.
Two weeks after the program, the focilitators fi-om Connections Inc will contact the
participants with the follow up survey. Follow-up surveys will be distributed in person to
those individuals who remain in the treatment center at the time o f the follow up. The
“contact information” available only to the Connections Inc. outreach worker will be used
to mail follow up surveys to those who have left treatment. Participants will be asked to
return the survey in a Self Addressed Stan(q>ed Envelope. The survey wiU measure:
• HIV and Hepatitis C transmission knowledge and beliefe,
• knowledge o f HIV and Hepatitis C counselii^ and testing services,
• knowledge o f harm reduction techniques,
• motivation to e n g ^ e in preventative behavior,
• feelings o f social support and perceived ability to establish social networks outside
o f the drug community,
• attitudes towards practicing HIV and Hepatitis C prevention interventions,
• perceptions o f personal vulnerability to HIV and Hepatitis C infection,
• perceived self-efficacy to perform preventative measure,
• perceptions o f personal ability to negotiate safe drug use, and
• perceived urgency to inject safely (please see attached survey questions).
Control Group
The outreach worker fi-om Connections Inc. will attend one o f the regularly scheduled
meetings at a second chemical dependency treatment center. At that meeting, she wiU ask
clients to voluntarily participate in the study. Those who wish to participate will be given a
written and verbal explanation o f the study as well as asked to read and sign an informed
consent. They will then be asked to complete the survey, and provide Connections Inc
with contact information where they can be reached two weeks later. Control group
participants will be asked to write a unique identifier at the top o f the survey for the
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purpose o f matching pre and posttests. To protect confidentiality the consents fijrms,
surveys, and contact information wül be collected separately. These volunteers vsdll not
receive any activities between the pre-test and the post-test. Two weeks later Connections
Inc. will conduct the outreach program Taking it to the Population at the treatment
center. Prior to the program, the facilitator will ask those individuals who participated in
the pre test to complete a posttest. Posttests will be collected and the clients wall receive
the prevention program. The “contact information sheet” will be used to contact clients
who are no longer at the treatment center. These individuals wall be maUed a posttest
survey and asked to return it in a Self Addressed Stamped Envelope.

6. BENEFITS OF THE RESEARCH
The Montana Department o f Public Health and Human Services (DPHHS) will use the
information firom this study to plan future HIV intervention programs for IDUs in
Montana. This study wall provide DPHHS, MCDC, Connections Inc., as well as other
health organizations with valuable insight concerning educational outreach programs as an
HIV and Hepatitis C intervention tool. Educational outreach programs, such as “Taking it
to the Population", that are used as interventions to prevent HIV and Hepatitis C infection
have the potential to reach a large number o f people in a cost effective way, as well as
have the possibility to lower rates o f future HIV and Hepatitis C infections. I f Taking to
the Population proves to be effective in promoting safer injection practices and helps
IDUs maintain changes, this intervention can easOy be replicated in other states and
implemented as a useful tool to reduce the spread o f HIV infection among IDUs.
7. RISKS AND DISCOMFORTS
• The participant wall be asked to disclose information about their injection drug
usage and behaviors. Disclosing o f this information may be uncomfortable for the
participants
• Participants may raise concerns or questions regarding their injection drug usage
and related issues.
• Although the survey wül be anonymous, the volunteers wül be asked to place
unique identifiers on each survey for purposes o f matching pre- and post-surveys.
• Participants will be asked to disclose o f contact information for the purpose o f the
follow up survey.
8. MEANS TO MINIMIZE EACH SUCH DELETERIOUS EFFECT
•

Participants woU receive an oral/ and or waitten explanation o f the contents o f the
survey before they are asked to participate in the study. It wül be explained that
participation is voluntary. If the content makes any participant uncomfbrtable, he or
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she may chose to withdraw from the study or leave questions unanswered. Participants
will be informed o f this before answering the survey questions, both by the educational
outreach focilitator and in the survey’s written instructions.
I f participating in the study raises concerns or questions regarding the individual’s
injecting drug use, he or she will have access to staff and other resources at the
treatment center.
Volunteers will be explained that participation in the educational outreach program
does not require them to participate in the study.
Volunteers wül be asked not to discuss any questions with the other participants in
order to protect their confidentiality.
Volunteers will not be asked to put their name on the survey.
Contact information will only be used to maü follow up surveys. This information is
confidential and only the HIV and Hepatitis C outreach educator who mails the
surveys, will have access to it. Upon sending a follow up survey, this information will
be destroyed.
Participants’ names will not be linked to the data or results o f this study. All data
gathered will be looked at as collective data, not individual.

9. PR O TEC TIO N O F TH E SU B JEC T’S PERSO N A L PRIVACY
Keeping all information confidential protects participants’ privacy. Individuals who
participate in this study wiU asked to read and sign a consent form. No names wül appear
on the surveys, rather, the volunteers will be asked to place a unique identifier on the preand post-test so that the subjects’ responses can be matched and compared pre and post.
Consent forms wül be stored in a separate location from the data, and wül be kept in a
locked filing cabinet in the Thesis Chair’s office, whüe data wül be kept in the graduate
assistant’s office, in a locked filing cabinet. Participants wül be asked to provide a contact
address for the purpose o f follow up surveys. Only the outreach worker from Connections
Inc. WÜ1 have access to the contact information, and it wül be destroyed upon mailing o f
the survey. The names o f participants and identifying information wül not be associated
with the data or with any o f the project reports. Maintaining confidentiality reduces the
greatest risk to the individual, which is the association o f their name with drug usage.
10. W R ITTEN CONSENT FO R M AND PA R TIC IPA TIO N INFO RM A TIO N
SHEETS
See attached subject information and informed consent form
11. W A IV ER O F W R ITTEN IN FO RM ED CONSENT
N ot applicable.
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TheUniveisityof

Montana

OfBce o f the Vice President
Reseaidi and Developmoit
UnivetsttyHaU 116
(4 0 ^ 243-6670
(406) 243-6330 Fax

Date: M arch 4,2004
To:

K . A nn Sondag, HH F

Fi-om: S h ^ la HofHand, IR B C hair
RE:

IRB action on your proposal tided: “AIDS and Hepatitis C Prevention Outreach
Intervention’’

The modifications to & e 11-point summaiy, participant Idttca, e]q>lanation o f the smdy, and die
Infonned C onsoit Form (ICF) satisfactorily address die conditions that die IRB placed on approval o f
die proposal cited above. Please use the “signed and dated” ICF as the “master” for preparing copies
for your study. Approval for this study is granted as o f die date o f diis memo and continues for one
year fiom the date o f the Conditional Approval. I f die study runs for more th a n one year, a
continuation must be requested. Also, you are required to notify die IRB if d m e are any significant
changes in die study or unanticipated o r advCTse evCTts occur during the study.

Sheila HofiOand

Attachment
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SU B JE C T IN FO R M A TIO N AND IN FO R M ED CO N SEN T FO RM
F O R SU RV EY PA R TIC IPA N TS
T itle: HIV and H epatitis C Educational Outreach Programs
S urvey P ro to co l no.: M 7625 Funding for diis project has been provided by the M ontana
D epartm ent o f Public H ealth and Human Services
C o n tac t P erso n s: Annie Sondag, H tone 406-243-5215, Healdi and Human Perform ance,
U niversity o f M ontana, M issoula, M T 59812; C o r ^ Campbell, H ealth and Human Perform ance,
U niversity o f M ontana, M issoula, M t 59812; Casey Rudd, Phone 406-556-1139,821 W est
M inden H all, Bozeman, M T 59715.
P u rp o se
The purpose o f this study is to detom ine if Takhtg it to the Population, an educational HIV and
H epatitis C prevention outreach program , held at in-patient chem ical dependency centers is
effective in prom oting safer injection practices among injection drug users. Tatdng it to the
Population fixuses on HIV and Hepatitis C risk behavior reduction, which incorporates 1) HIV
and H epatitis C preventative information 2) H IV and Hepatitis C preventative m otivation 3) and
H IV and H epatitis C preventative behavior skills. The likelihood that individuals w ill be likely
to initiate and m aintain patterns o f HIV and H epatitis C prevartative bdhavior depends on the
extent to w hich individuals are well inform ed, m otivated to act, and possess tire behavior skills to
act effectively
P ro ced u re
Participation in this smdy is voluntary. I f you agree to take part in this research sm dy you w ill be
asked to fill out tw o surveys, tw o weeks a p a rt W e ask that you do not put your name on the
survey. H ow ever, please place tiie last four digits o f your social security num ber on the survey in
order fo r us to m atch and com pare survey responses pre and p o st This survey asks about
preventative knowledge, m otivation, and behavioral skills relevant to injection drug users. This
survey w ill take about 10 to 15 m inutes to conq>lete. A ll consort fim ns and data w ill be stored in
s ^ a ra te locked filing cabinets in the project director*s office. In no way will the r^earch ers link
your identity w ith tire survey.
R isks a n d D iscom forts
# Y ou will be asked to disclose inform ation about your injection drug usage and behaviors.
D isclosing o f this inform ation m ay b e uncom fortable for you.
Y ou m ay be concerned about your privacy and confidentiality. A ltiio u ^ your nam e w ill
n o t be associated w ith the inform ation collected for this project, or with any reports, you
m ay have concerns that your identity as a participant in this smdy w ill becom e known.
M ethods fo r redu cin g risk
# Y ou can withdraw firom the project at any tim e if you feel personal discom fort I f you
feel uncom fortable answering a question, you can leave it blank.
• I f you would like m ore infoimaticm o r someone to talk to after the study, the treatm ent
center staff and outreach facilitator w ill be available to talk w ith you.
• Y our nam e and identity w ill not be associated w ith the data o r any o f the project reports
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Benefits
Y our help w ith this project w ill provide valuable inform ation to the M ontana Departm ent o f
Public H ealth and Human Services. B y participating in this project, your answers will help staff
offer services and develop program s to m eet the needs o f IDUs in M ontana.

Confidentiality
A ll o f die inform ation we collect here today is com pletely crm fidential. W e w ill not identify any
o f the participants. For exam ple, we w ill not use your name, or any other identifying inform ation
in reports or other m ato ials related to this study.
1. Participants* identities w ill rem ain anonymous and w ill not be associated with
inform ation in any way.
2. A t the crm clusion o f the study, any inform ation pertaining to participants* identities w ill
be destroyed.
3. Data w ill be stored in a locked filing cabinet in the researcher's locked office at the
U niversity o f Mcmtana.
4. A ll data w ill be reported as group data; no individual data w ill be reported.

Compensation for injury
Although w e do not foresee any risk in taking part in this study, the follow ing liability states is
required in all U niversity o f M ontana consent forms:
“In the event that you are injured as a result o f this research you should individually seek approbate
medical tre^m ent If the injury is caused by the négligence of the University or any o f its en^loyees, you
may be entitled to reimbursement or cœnpensaticm pursuant o f the Comprehensive State hrsurance Plan
establidred by the dquutment o f Administration under the authority o f M CA Title 2, and Chapter 9. In
the event o f a claim or sudr injury, further information may be curtained from the University’s claims
Representative or University Legal Counsel.**

Voluntary participation/witbdrawal
Y our decision to take part in this project is entirely voluntary. You m ay withdraw from fids
project for any reasons and at anytim e w ithout any penalty.

Questions
I f you have any questions about this project now or later, you m ay contact Annie Sondag 406243-5215, o r Casey Rudd 406-556-1139.
I have read the above desœ ption o f this study. I have been informed o f the risks and benefits
involved, and all o f m y questions have been answered to my satisfrction. Furthermore, I have
been assured that a m em ber o f the study team w ill answer any fiirtfaer questions 1 m ay have. I
volim tarily agree to take part in this study. I am at least 18 years o f age. I understand that I w ill
receive a copy o f this consent form.

Signature:__________________________________________ Date_________________
Thank you very muchfo r your participation!
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P ro po sa l

T ^O SW E D
The Umvecsity o f M ontana

FEB OG 2BB4

INSTITUTIONAL REVIEW BOARD (IRB)
C H EC K LIST

O w cklist, including any icquind attadmieab^ fiir cadi pngect involving human autjeos.
Tnc lKB mce(3 monthly to evaluate proposal», and approval is imrally granted for one year. See IRB CuUlelines and
Procedures for deiaila.

F to je c tD ire c to n _ J ^ jL flu o
Signature: * 4 ^

I
(j, w ». ----- . .

Dept.:
.

J
,

.

_ _ Date:

Phone: 5 Q
E -m ail:giy\iC . *ipi^<Ac
a - L - g>*Tf~

Co-Directoi(s):__________________________________ DepL:________________
Project Tide: ^ [ p S - /artct

«O.-.'V tTa.c tw

Phone:_________
JIC,

ProjectDescnption:_]]Lf P v rp g S y ..a E .T k i'^ -g o frc A ' i s 4 a «A etrrw niftf tlLu g - t^ g V
f r iiKwteçhnicalbngaagcL^an
t r ^ f L i o W J H r g ,+ i ^ n n tT -^.
^ e \A .lo T k n u icirr\— o£.—
,»f â d r u g —
—i o — t ^aAl vJ—
ftiDA
____
..■lefcr^aAi Vi ■4 C . p r c J tv A i fiiTV. ------------ 1-------- A---------------------------- £______________________________
All mveatigatoni on lids project imut complete die seU^gtndy comae on prolectiMt offanmanieacaichaubjecia, available at the
UM IRB wdwite: hnp://www.uinLedii/iBaearch/irb.taim.
Certificatioii: |/W e bave corqiletBd the oottise - (Use additional page if neceaaery)
Sigaaluiei
Date
.
Signatme
agaalm ei
Dale

Dale

ÈÈZÔ+
S tndents Only:
Faculty Supervisor__________________

D qpt:_________ Phone:_______

S ig n a tu re :___________ __ ______________________________________________________

ÇMy aignanae conftnns that I have read the IRB ChnrJfHat and attachments and agiee that it accurately
Rjnesaits the plamiBd reseaieh and dut I win aqpeivise dus leaeoich projecL)
For IRB Uae Only

CRB D eterm ination:
Approved Exemption firom R eview — Exemption #_______________
Approved by Expedited/Administrative Review

X Full IRB Determination:
Approved

X Conditional Approval (see attached memo)
Resubmit Proposal (see attached memo)
Dis^qjrovcd (see attacfied m ono)
Signature IRB Chair:

^ ______________ Date:_^,
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# 3 3 0 4

The University of

Montana

Office o f Research
Univrasity Hall 116
243-6670
FAX 243-6330

D ate: F eb ru ary 19,2004
T o:

K . A nn Sondag, HH P

From : Sheila H offland, IRB C hair
RE:

IR B action on your proposal titled: “AIDS and Hepatitis C Prevention Outreach
Intervration”

Attached is die BRB Checklist, which shows that the IRB at its February 17,2004 meeting gave
“Conditiooal Approval" to your proposal. Once the conditions have been satisfied and diis has been
reported back to the IRB, fhial approval to initiate the project will be granted. A revised Informed
Consent Form, along widi the odier paperwork, will need to be r^um ed. I will place a “dale stamp
approval” and return it to you. This wiU diea be used as a “master” tor making your copies. The
conditions are as follows:
Participant L etter
The first use o f IDUs should have it spelled out, in case the individual is not fiuniliar with the
term.
A coding method other dian die last four numbers o f a Social Security # should be used.
Informed Consent Form:
- Protection o f die Subject’s Personal Privacy, 6*" sentence: It indicates a “graduate assistant’s
office” but nowhere else in die proposal does it include a graduate assistant Please clarify.
- Voluntary Participation/W ithdraw^: Expand diis section to include a statement regarding the
participant can wididraw witiiout any penalty.
Explanation o f the Stuc^
Is this explanation being given pre- or post-survey?
4* sentence: The survey cannot be confidential and anonymous at the same time. Please
change the wording.

Sheila Hoffland
IRB Chair
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A P P E N D IX B

HIV Prevention Intervention Survey 2004
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AIDS and Hepatitis C Prevention Outreach
Dear Participant,
Thank you for taking tbe time to parüâpate in this su rv ^ . This survey asks about knowledge, motivation,
and behaviors relevant to injection drug use. The results will be used to help develop future AIDS and
Hq>atitis C educatitmal outreach programs for people who use injection drugs and to assess whether or
not tile programs make a dififetence. The Montana Department o f Health and Human Services (DPHHS)
is also interested in using the résulte in tiieir AIDS and Hepatitis C prevaation work. Most importantly, by
participating in the study you can a s ^ otiier people uAo use ngection &ugs in beuefitii^ foom HTV and
Hepatitis C preventioa outreadi programs in the future.

Instrucfiona:
Ypiir pi^içiiJation is ^ntirply Volunt?^vIf,ybtt feel uncbtoifoitabreahswering a question,
just leave :U!blaiilb ïîo w e y ^ ^ é ffl^
ypu do; answer; le more help
your survey
be jto prgaic&tibity
apb ^ ipatilis Ç preventtion work. This
is a completely WopympUs sutveÿ^^P tiQf^
àttytyhere on thesefonns;;
However, please Pirplp
mPU& you tyei^ jbprd, ianiv^^ %1iie jgr^thieel ettersbfyour
motlier*s 6rst name at 6 e fop 9^
#iY eÿ; If you l ^ e a ny questions, piease asic one o f
the focilitatois who w iÉ be happy to help you.

Only the lesearcbos from The University o f Montana cmiducting this study will have access to the data.
No pmsonal information will be disclosed or ^ipear in any rq m rt For the purpose o f matching follow up
surveys, your answers will be tracked <mly by code num b*. Should you have any questions or concerns,
please ask the person handing out the survey or contact one o f the researdbers.
We want to thank you a ^ in fortaking the time to participate in this study, which is funded by the
Montana Department o f Public Health Human Services; STD/AIDS Section. Your participation is greatly
appreciated and valued.
Sincerely,

C o r^ Campbell, Researcher
The Univ*sity o f Montana

Annie Sorklag, Researcher
The University o f Montana
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Jan..

;f# W , :

Jûl ÿyp. : ^^:

Î7
2.
3.
4.

.

A person can get AIDS or Hepatitis C by injecting with
a dirty needle.
..
A p®eon can get AlDS pr Hepatl&^
useQ ipriattpqing.
,
...... ... ,
A person can get AIDS or Hepatitis C by having sex
with someone who has shared needles, cookers, or
cotton.

Nov^;, Dec

N6n

:
Yes

No

r le isu r e
Not Sure
Not Sure

Yes

No

Not Sure

Not Sure
or riepauos y py ipoKing ai mem. i
,
Yes
Not Sure
No
6. 1know where to get dean needles, cottons, and
cookers.
•NO ; Not Sure
7. W heniam m ptintm aW
get helpifrorn jÿ^ple Jke add
ptrtreac^ wbrkër&;ànæ^
Yes
No
Not Sure
When
1finish tois treatment program 1want to contact
8.
an organization like Connections, Inc. that will help me
find resources such as jobs and housing.
r
Not Sure
9. ! know where fo get tested for AID$ #hd Hepatitis C ,
Not Sure
No
10.1 am confident i will get tested tor AIDS and Hepatitis C Yes
in the next six months.
•Yes; ‘ ■ n ç T ' ~ P IjNot Sure
of ; ;;
1ll 1am concerned about :^ethef kg
;I ç g / a & f M O W
i j ly i i ^ a i u 'i
v w y ;# »
w
me:
V.
r
.
Not Sure
Yes
No
12. When 1finish this treatment program 1will probably
hang out with friends who inject drugs.
5

"T?— Tw nr

ask my non-using ifiiendslâriÉl family f # help with my
p r p b l^ s
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IF le a s e fill out the se questions by circling the answ er th a t best describes ycur
’ response to each statem e nt

14. i am not at
for AIDS or Hepatitis C because if I
inject drugs, I always inject safely._________________
15; I arh not-at risk for AIDS or H epai^ G because if I: ■ :
inject; drugs, I kpow thd people I shjprn
cottons, and cookers with dbnY have AIDS dr Hepatitis

Yes

No
l No7

1 6 .1am confident that if I inject drugs I can always get
Yes No
clean needles for injecting.
17 l am confident that if I injec# cimgs
Yes No
'
■clean needle, cooker, and cotton: ;
18. I am confident fliat if I inject drugs I know how to clean Yes No
and disinfect needles and cookers and get dean
cotton.
19 In: the^future to pmtect mysélf against AlpS or H epat# Yee
No
ci, tt l ihjed diugs, I plan 0
dean héedley
cooker, and a new idottdn to protectthyself against :i
AIDS or Hepatitis C
7
,..L . :
20. In the future, if I have sex, I will practice safer sex (use Yes
No
c o n d o m s ) . ________________________
2ih WlieriTfinish thWtreatment program I planed discuss TYea^ No
AIDS and Hepatitis C with my m h d s.
K
f
'J.
22. in the future, if I inject drugs, I would feel comfortable
Yes No
insisting on using dean needles, cottons, and cookers
with a fhend(s).
23; In tbefuture, if r inject drugs;, l Ayp
: Yes No
if a friend of,mine asked me tojriject%&h a "dirty''
• • neediè?'v\-::.y^.V
25. In the ttiture, if I inject drugs, I would be able to stop
Yes No
myself from ejecting if my fr^ d s or I don't have a
dean needle?
Yes No
26 . I am more comfortable getting information about AIDS
or Hepatitis C if the pemoh who tells nre about them ie
a former Injection Drug Ueer because he or she can '
.relate.to me:■; ... :
'
■
27. It is very important to me that the person who talks to
Yes No
me about AIDS and Hepatitis C is genuinely
concerned about me.
_____
_______
28. It vèryTim^rtarnto m eti^t I can WsEthe pemOh T~~ Yes No
who talks to me about AIDS or Hepatitis C:
h

Not
Sure
Not
Sure

Does not
apply to me
Does not
apply to me.

Not
Sure
Not
Sure
Not
Sure

Does not
apply to me
Does not
apply to me
Does not
apply to me

Not
Sure

Does not
a ^ tome
■.

Not Does not
Sure apfriytome
Not: Does not
' sum apply to me
Not
Does not
Sure apply to me
'Not
Sure

Ddesnot
apply to me

Not
Sure

Does not
apply to me

Not
Sure

Does not
apply to me

Not
Sure

Does not
apply to me

Not” Does not
Sure apply to me
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29. It is very important to me that the person who talks to
me atxiut AIDS and Hepatitis C seem s very
knowledgeable about ways to reduce AIDS and
Hepatitis C Infection.____
30. It is yery^important to rpe that #@]peMpn wh
me abptitAipS
O shoV^

Yes

No

Not
Sure

Does not
apply to me

No
i

Not
Sure

Does not
apply to me

No

Not
Sure

Does not
apply to me

üri^r^ndihgimYdiàhity,^^
31. It is very important to ine that the person who talks to Yes
me about /MDS or Hepatitis C respects me by
accepting the fact that I have the right to make my own
decisions at>out drug use.
FOR

mXT Q # ^ p N ,f

BEST
#

Ê3Never

'

hïÈ^ùeèit''/:,:'

Please answer the following questions about yourself.
33. Age:_____ years
34. Biological Sex (sex at birth):
□ Male
□ Female
35. What is your sexual orientation?
□ Heterosexual/straight
□ Bisexual

□ Homosexual/Gay or Lesbian
□ Unsure

36. Are you married or In a committed r^ationWiip?

□ Yes

37. Do you have children? □ Yes
Ifyes.Oi
02
03
04

07+

□ No.
05
06

D No

38. What is the highest level of education you have completed?
O Less then high-school
O Some college
O High School Graduate/GED
o College Graduate
□ Trade Vocational School
O Graduate/Professional School
39. Are you employed or do you have other regidar income?
D Yes
□ No
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40. Which of the following categories represents your individual yearly income (ttie
amount you would claim on your income tax forms)?
D 100,000+
□ 20,001 - 35,000
□ 75,001 -100,000
a 10,001 - 20,000
0 50,001 - 75,000
□ 6,000- 10,000
□ 36,001 - 50,000
O < 6,000
41. Have you ever been in jail or prison?
□ Yes
□ No
42. Are you a substance user?
O Yes
□ No
If so what substance?
43. Have you ever injected drugs?
□ Yes
DNo
44. Have you ever shared injection equipment?
□ Yes
ÜNo
45. Have you been tested for AIDS?
□ Yes
□ No
If so what were the results? □ Positive

□ Negative

□ Don't know

46. Have you even been tested for Hepatitis C?
D Yes
□ No
If so what were the results? □ Positive

□ Negative

D Don't know

47. Have you ever been diagnosed with a mental illness?
O Yes
□ No
If yes, which one?__________________________
48. Do you take prescription meds?
□ Yes
□ No
If yes, which ones?__________
49. How many times have you been to treatment?
01
02
03
04
05
06
0 7+
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50. With which of the following do you identify?
O White (non-Hispanic)
□ American Indian/Alaska Native
□ Black/African American (non-Hispanic)
□ Hispanic/Latino/Chicano
D Asian/Padfic American
□ Bi-racial or multi-racial/ethnic (Please specify),
O Other (Please specify)___________________
51. Have you been to Casey’s presentation before? No Yes
If so, how many tim es?_____________
Approximately when was the last time you attended? Month

Year_

52. Do you have any questions or comments?

Thank you very much for taking the time to complété this survey!
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APPENDIX C
Informed Consent Form
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SUBJECT INFORMATION AND INFORMED CONSENT FORM
for Survey Participants
Title: HTV and Hepatitis C Educational Outreach Programs
Survey Protocol no.: M7625 Funding for this project has been provided by the Montana
Department o f Public Health and Human Services
C ontact Persons: Anme Sondag, Phone 406-243-5215, Health and Human Performance,
University o f Montana, Missoula, MT 59812; Corey Campbell, Health and Human
Performance, University o f Montana, Missoula, Mt 59812; Casey Rudd, Phone 406-5561139, 821 West Minden Hall, Bozeman, MT 59715.
P urpose
The purpose o f this study is to determine if Taking it to the Population^ an educational
HTV and Hepatitis C prevention outreach program, held at in-patient chemical
dependency centers is effective in promoting safer injection practices among injection
drug users. Taking it to the Population focuses on HIV and Hepatitis C risk behavior
reduction, which incoiporates 1) HTV and Hepatitis C preventative information 2) HIV
and Hepatitis C preventative motivation 3) and HIV and Hepatitis C preventative
behavior skills. The likelihood that individuals will be likely to initiate and maintain
patterns o f HIV and Hepatitis C preventative behavior depends on the extent to which
individuals are well informed, motivated to act, and possess the behavior skills to act
effectively
P rocedure
Participation in this study is voluntary. If you agree to take part in this research study you
will be asked to fill out two surveys, two weeks apart. We ask that you do not put your
name on the survey. However, please place the last four digits o f your social security
number on the survey in order for us to match and compare survey responses pre and
post. This survey asks about preventative knowledge, motivation, and behavioral skills
relevant to injection drug users. This survey will take about 10 to 15 minutes to complete.
All consent forms and data will be stored in separate locked filing cabinets in the project
director’s office. In no way will the researchers link your identity with the survey.
Risks and Discomforts
• You will be asked to disclose information about your injection drug usage and
behaviors. Disclosing o f this information may be uncomfortable for you.
You may be concerned about your privacy and confidentiality. Although your
name will not be associated with the information collected for this project, or with
any reports, you may have concerns that your identity as a participant in this study
will become known.
M ethods for reducing risk
• You can withdraw from the project at any time if you feel personal discomfort. If
you feel uncomfortable answering a question, you can leave it blank.
• If you would like more information or someone to talk to after the study, the
treatment center staff and outreach facilitator will be available to talk with you.
• Your name and identity will not be associated with the data or any o f the project
reports
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Benefits
Your help with this project will provide valuable information to the Montana Department
o f Public Health and Human Services. By participating in this project, your answers will
help staff offer services and develop programs to meet the needs o f IDUs in Montana.
Confidentiality
All o f the information we collect here today is completely confidential. We will not
identify any o f the participants. For example, we will not use your name, or any other
identifying information in reports or other materials related to this study.
1- Participants’ identities will remain anonymous and will not be associated with
information in any way.
2. At the conclusion o f the study, any information pertaining to participants’
identities will be destroyed.
3. Data will be stored in a locked filing cabinet in the researcher’s locked office at
the University o f Montana.
4. All data will be reported as group data; no individual data will be reported.
Com pensatioii for injury
Although we do not foresee any risk in taking part in this study, the following liability
states is required in all University o f Montana consent forms:
“In the event that you are injured as a result o f this research you should individually seek
appropriate medical treatment. I f the injury is caused by the negligence o f the University or any
o f its em ployees, you may be entitled to reimbursement or compensation pursuant o f the
Comprehensive State Insurance Plan established by the department o f Administration under the
authority o f M CA, Title 2, and Chapter 9. In the event o f a claim or such injury, further
information may be obtained from the University’s claims Representative or University Legal
C ounsel.”

Voluntary participation/withdrawal
Your decision to take part in this project is entirely voluntary. You may withdraw from
this project for any reasons and at any time without any penalty.
Q uestions
If you have any questions about this project now or later, you may contact Annie Sondag;
406-243-5215, or Casey Rudd 406-556-1139.
I have read the above description o f this study. I have been informed o f the risks and
benefits involved, and all o f my questions have been answered to my satisfaction.
Furthermore, I have been assured that a member o f the study team will answer any
further questions I may have. I voluntarily agree to take part in this study. 1 am at least 18
years o f age. I understand that I will receive a copy o f this consent form.
Signature:______________________________________________Date__________________
Thank you very much fo r your participation!
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APPENDIX D
Explanation o f the Study
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EXPLANATION OF THE STUDY
This study is an outcome evaluation o f the HTV and Hepatitis C prevention educational outreach
program called “Taking it to the Population”. We have developed a survey that asks about
knowledge, motivation, and behaviors relevant to injection drug use. This is a completely
anonymous survey. The following are possible risks and discomforts associated with participation in
this study.

•
•
•

•

You will be asked to disclose information about your injection drug usage and
behaviors. Disclosing o f this information may be uncomfortable for you.
You may raise concerns or questions regarding your injection drug usage and related
issues. This may be uncomfortable for you.
Volimteers will be asked to place their name and contact address on a separate sheet
o f paper. This contact information will only be used to mail follow up surveys. This
information is confidential and only Casey Rudd, the HIV and Hepatitis C outreach
educator, will have access to it. (Correction Connections, the University o f Montana,
Montana DPHHS will not have access to this information). Upon sending a follow up
survey, this information will be destroyed.
Volunteers will be asked to place unique identifiers on each survey for purposes o f
matching pre- and post-surveys.
The results will be used to help us refine future HIV and Hepatitis C educational outreach

programs for IDUs and assess the outcome o f participating in these HTV and Hepatitis C educational
outreach programs. The Montana Department o f Health and Human Services (DPHHS) is also
interested in using the results in their HIV and Hepatitis C prevention work. Most importantly, by
participating in the study you can assist other IDUs in benefiting from educational outreach programs
such as this one.
Only the researchers from the Health and Human Performance Department at the University
o f Montana conducting this study will have assess to this data. N o personal information will be
disclosed or appear in any report. For the purpose o f mailing follow up surveys, if you chose you will
have to disclose your contact information. When the data have been fully analyzed, a summary o f the
results will be available for volunteers to read through the HHP department at the University o f
Montana.
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